<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">39982</article-id><article-id pub-id-type="doi">10.7554/eLife.39982</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>The Crohn’s disease polymorphism, <italic>ATG16L1</italic> T300A, alters the gut microbiota and enhances the local Th1/Th17 response</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-118379"><name><surname>Lavoie</surname><given-names>Sydney</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-2890-3634</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-23013"><name><surname>Conway</surname><given-names>Kara L</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-118380"><name><surname>Lassen</surname><given-names>Kara G</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-7023-461X</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-127472"><name><surname>Jijon</surname><given-names>Humberto B</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-118381"><name><surname>Pan</surname><given-names>Hui</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-118382"><name><surname>Chun</surname><given-names>Eunyoung</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-118383"><name><surname>Michaud</surname><given-names>Monia</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-118384"><name><surname>Lang</surname><given-names>Jessica K</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-118385"><name><surname>Gallini Comeau</surname><given-names>Carey Ann</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-118386"><name><surname>Dreyfuss</surname><given-names>Jonathan M</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-118387"><name><surname>Glickman</surname><given-names>Jonathan N</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-57321"><name><surname>Vlamakis</surname><given-names>Hera</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-118388"><name><surname>Ananthakrishnan</surname><given-names>Ashwin</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" equal-contrib="yes" id="author-56039"><name><surname>Kostic</surname><given-names>Aleksander</given-names></name><email>Aleksandar.Kostic@joslin.harvard.edu</email><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset1"/></contrib><contrib contrib-type="author" corresp="yes" equal-contrib="yes" id="author-28627"><name><surname>Garrett</surname><given-names>Wendy S</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-5092-0150</contrib-id><email>wgarrett@hsph.harvard.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con15"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" equal-contrib="yes" id="author-32475"><name><surname>Xavier</surname><given-names>Ramnik J</given-names></name><email>xavier@molbio.mgh.harvard.edu</email><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con16"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution content-type="dept">Department of Immunology and Infectious Diseases</institution><institution>Harvard T. H. Chan School of Public Health</institution><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution content-type="dept">Department of Genetics and Complex Diseases</institution><institution>Harvard T. H. Chan School of Public Health</institution><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution content-type="dept">Gastrointestinal Unit, Center for the Study of Inflammatory Bowel Disease</institution><institution>Massachusetts General Hospital</institution><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution>Broad Institute of Harvard and MIT</institution><addr-line><named-content content-type="city">Cambridge</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution content-type="dept">Center for Computational and Integrative Biology</institution><institution>Massachusetts General Hospital</institution><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff><aff id="aff6"><label>6</label><institution>Joslin Diabetes Center</institution><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff><aff id="aff7"><label>7</label><institution content-type="dept">Department of Pathology</institution><institution>Harvard Medical School</institution><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff><aff id="aff8"><label>8</label><institution>Beth Israel Deaconess Medical Center</institution><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff><aff id="aff9"><label>9</label><institution content-type="dept">Department of Microbiology and Immunobiology</institution><institution>Harvard Medical School</institution><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff><aff id="aff10"><label>10</label><institution content-type="dept">Department and Division of Medical Oncology</institution><institution>Dana-Farber Cancer Institute and Harvard Medical School</institution><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Cadwell</surname><given-names>Ken H</given-names></name><role>Reviewing Editor</role><aff><institution>Skirball Institute of Biomolecular Health</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Taniguchi</surname><given-names>Tadatsugu</given-names></name><role>Senior Editor</role><aff><institution>Institute of Industrial Science, The University of Tokyo</institution><country>Japan</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>22</day><month>01</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>8</volume><elocation-id>e39982</elocation-id><history><date date-type="received" iso-8601-date="2018-07-11"><day>11</day><month>07</month><year>2018</year></date><date date-type="accepted" iso-8601-date="2018-12-20"><day>20</day><month>12</month><year>2018</year></date></history><permissions><copyright-statement>© 2019, Lavoie et al</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Lavoie et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-39982-v1.pdf"/><abstract><object-id pub-id-type="doi">10.7554/eLife.39982.001</object-id><p>Inflammatory bowel disease (IBD) is driven by dysfunction between host genetics, the microbiota, and immune system. Knowledge gaps remain regarding how IBD genetic risk loci drive gut microbiota changes. The Crohn’s disease risk allele <italic>ATG16L1</italic> T300A results in abnormal Paneth cells due to decreased selective autophagy, increased cytokine release, and decreased intracellular bacterial clearance. To unravel the effects of <italic>ATG16L1</italic> T300A on the microbiota and immune system, we employed a gnotobiotic model using human fecal transfers into <italic>ATG16L1</italic> T300A knock-in mice. We observed increases in <italic>Bacteroides ovatus</italic> and Th1 and Th17 cells in <italic>ATG16L1</italic> T300A mice. Association of altered Schaedler flora mice with <italic>B. ovatus</italic> specifically increased Th17 cells selectively in <italic>ATG16L1</italic> T300A knock-in mice. Changes occur before disease onset, suggesting that <italic>ATG16L1</italic> T300A contributes to dysbiosis and immune infiltration prior to disease symptoms. Our work provides insight for future studies on IBD subtypes, IBD patient treatment and diagnostics.</p></abstract><abstract abstract-type="executive-summary"><object-id pub-id-type="doi">10.7554/eLife.39982.002</object-id><title>eLife digest</title><p>Trillions of bacteria live inside the human gut. From helping to digest our food to producing vitamins, these bacteria can have a big impact on our health, yet some people tolerate these bacteria better than others. In some cases, the body reacts badly to its own bacteria, stimulating an over-exuberant immune response. The gut becomes too inflamed, causing pain and diarrhoea, which could lead to an inflammatory bowel disease such as Crohn’s disease or ulcerative colitis. The symptoms of inflammatory bowel disease can vary from person to person, and how someone responds to treatment can be as individual as the symptoms as well.</p><p>The causes of inflammatory bowel disease are complex; our genes, immune system and gut bacteria all play a role. Previous research has found hundreds of mutations in our genes that increase a person’s risk of developing inflammatory bowel disease. No single mutation is the root cause for every one person with inflammatory bowel disease, and individuals with these mutations may not even develop the condition. For those who do develop the disease, certain immune cells can be found in high numbers, such as the white blood cell known as Th17 cells. People with inflammatory bowel disease may also house different bacteria compared to someone with a healthy gut. In some cases of inflammatory bowel disease, there are elevated amounts of one type of bacteria called <italic>Bacteriodes</italic>. It is not clear how these mutated genes, the types of bacteria that live inside our gut, and the immune response are all related.</p><p>Lavoie et al. focused on a mutated gene, known as <italic>ATG16L1T300A</italic>, which increases risk of Crohn’s disease in humans, and the experiments compared mice that had this human mutated gene with those that did not. The mice started off germ-free, meaning that they did not have any gut bacteria. Lavoie et al. then exposed the mice to samples of human stools, which contain gut bacteria, and after a month they analysed the guts of the mice. On average, the mutant mice had more <italic>Bacteriodes</italic> and Th17 cells in their guts than the normal mice. However, none of the mice developed inflammatory bowel disease, suggesting that changes to gut bacteria and immune cells may occur before the disease can be diagnosed.</p><p>Together these findings show how just one mutated gene affects the bacteria and immune cells in the gut; but there are hundreds of other known mutations linked with inflammatory bowel disease. By unravelling the effects of more of these mutations, scientists could begin to learn more about the causes of this condition, and potentially improve its treatment options.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>Bacteroides</kwd><kwd><italic>Bacteroides ovatus</italic></kwd><kwd>Crohn's Disease</kwd><kwd>gut</kwd><kwd>T cell</kwd><kwd>ATG16L1T300A</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>CA154426</award-id><principal-award-recipient><name><surname>Garrett</surname><given-names>Wendy S</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>DK092405</award-id><principal-award-recipient><name><surname>Garrett</surname><given-names>Wendy S</given-names></name><name><surname>Xavier</surname><given-names>Ramnik J</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>DK105653</award-id><principal-award-recipient><name><surname>Lavoie</surname><given-names>Sydney</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100001341</institution-id><institution>Richard and Susan Smith Family Foundation</institution></institution-wrap></funding-source><award-id>Smith Family Foundation Award for Excellence in Biomedical Research</award-id><principal-award-recipient><name><surname>Kostic</surname><given-names>Aleksander</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>DK097485</award-id><principal-award-recipient><name><surname>Xavier</surname><given-names>Ramnik J</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>DK110499</award-id><principal-award-recipient><name><surname>Garrett</surname><given-names>Wendy S</given-names></name><name><surname>Xavier</surname><given-names>Ramnik J</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Gnotobiotic and conventional mouse models of the IBD ATG16L1T300A SNP reveal gene-microbiota-immune interactions.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Crohn’s disease (CD) and ulcerative colitis (UC), the two main forms of inflammatory bowel disease (IBD), are characterized by chronic relapsing inflammation of the gastrointestinal tract (<xref ref-type="bibr" rid="bib55">Podolsky, 2002</xref>; <xref ref-type="bibr" rid="bib72">Turpin et al., 2018</xref>). The etiology of IBD is complex, as host genetics, the gut microbiota and environmental exposures all contribute to disease pathogenesis (<xref ref-type="bibr" rid="bib74">Xavier and Podolsky, 2007</xref>; <xref ref-type="bibr" rid="bib18">Garrett et al., 2010a</xref>). A breakdown in the ability of a genetically susceptible host to respond appropriately to the gut microbiota may lead to an overactive local immune response (<xref ref-type="bibr" rid="bib65">Sartor, 2008</xref>; <xref ref-type="bibr" rid="bib13">Eckburg and Relman, 2007</xref>) initiating the chronic cycle of intestinal inflammation core to IBD. Many genes within IBD loci are directly involved in pathways controlling the sensing and innate responses to bacteria (<xref ref-type="bibr" rid="bib74">Xavier and Podolsky, 2007</xref>; <xref ref-type="bibr" rid="bib29">Jostins et al., 2012</xref>). The relatively longstanding observation that there is an absence of intestinal inflammation in several gnotobiotic mouse models of spontaneous colitis maintained under germ-free housing conditions supports this idea (<xref ref-type="bibr" rid="bib14">Elson et al., 2005</xref>; <xref ref-type="bibr" rid="bib66">Sellon et al., 1998</xref>). Furthermore, data from IBD patients demonstrating that diversion of the fecal stream greatly improves symptoms (<xref ref-type="bibr" rid="bib62">Rutgeerts et al., 1991</xref>; <xref ref-type="bibr" rid="bib46">McIlrath, 1971</xref>) as well as reduces inflammatory cytokine levels (<xref ref-type="bibr" rid="bib10">Daferera et al., 2015</xref>) also lends plausibility to this concept.</p><p>Dysbiosis of the gut microbiota, including alterations in frequency, diversity and richness of microbial populations (<xref ref-type="bibr" rid="bib44">Manichanh et al., 2006</xref>; <xref ref-type="bibr" rid="bib51">Ott et al., 2004</xref>), has been associated with IBD (<xref ref-type="bibr" rid="bib47">Morgan et al., 2012</xref>; <xref ref-type="bibr" rid="bib16">Frank et al., 2007</xref>; <xref ref-type="bibr" rid="bib73">Willing et al., 2009</xref>). For example, a reduction in the abundance of the phylum Firmicutes, including the genus <italic>Clostridium</italic> (<xref ref-type="bibr" rid="bib56">Rajilić-Stojanović et al., 2013</xref>) as well as Proteobacteria and Actinobacteria, has been associated with IBD (<xref ref-type="bibr" rid="bib16">Frank et al., 2007</xref>). In contrast, there is variation in the abundance of <italic>Bacteroides</italic> in IBD (<xref ref-type="bibr" rid="bib67">Swidsinski et al., 2002</xref>; <xref ref-type="bibr" rid="bib68">Swidsinski et al., 2005</xref>; <xref ref-type="bibr" rid="bib20">Gophna et al., 2006</xref>; <xref ref-type="bibr" rid="bib58">Rehman et al., 2010</xref>; <xref ref-type="bibr" rid="bib7">Chu et al., 2016</xref>), including an increase in <italic>Bacteroides fragilis</italic> (<xref ref-type="bibr" rid="bib68">Swidsinski et al., 2005</xref>; <xref ref-type="bibr" rid="bib20">Gophna et al., 2006</xref>). Additionally, certain microbes, including <italic>Ruminococcus gnavus</italic>, are able to thrive in the high levels of oxidative stress in the inflamed gut and are associated with increased disease activity (<xref ref-type="bibr" rid="bib22">Hall et al., 2017a</xref>). A population-based metagenomics analysis found associations between fecal levels of secreted proteins and microbiome composition (<xref ref-type="bibr" rid="bib77">Zhernakova et al., 2016</xref>). Additionally, the unique ileal transcriptome of CD patients is associated with alterations in Firmicutes (<xref ref-type="bibr" rid="bib21">Haberman et al., 2014</xref>), implicating a role for genetics in shaping the microbiota. Genome wide association studies have shown that host genetic variants play a role in microbial dysbiosis (<xref ref-type="bibr" rid="bib23">Hall et al., 2017b</xref>). Further supporting the idea that these microbial alterations could be the driving force behind the immune response, microbial changes have been observed prior to onset of disease symptoms and specific microbiota signatures are associated with disease location (<xref ref-type="bibr" rid="bib27">Imhann et al., 2018</xref>). While data suggest a dynamic interplay between the microbiota, the immune system and disease pathophysiology (<xref ref-type="bibr" rid="bib52">Palm et al., 2015</xref>), how dysbiosis manifests and more specifically how individual species are affected by host genetics is less well understood. Because there is substantial diversity in disease location, symptoms and genetic susceptibility in IBD, understanding how specific microbial alterations occur will be important for identifying disease subtypes as well as developing precision medicine treatment options. Genetic diversity among patients is a compounding factor with respect to disease phenotype, suggesting that specific risk loci may play a role in underlying microbial community makeup.</p><p>Genome-wide association studies have linked over 230 genetic risk loci to increased IBD risk (<xref ref-type="bibr" rid="bib29">Jostins et al., 2012</xref>; <xref ref-type="bibr" rid="bib41">Liu et al., 2015</xref>; <xref ref-type="bibr" rid="bib12">de Lange et al., 2017</xref>; <xref ref-type="bibr" rid="bib43">Luo et al., 2017</xref>). The microbiota and disease severity have also been linked to genetic risk (<xref ref-type="bibr" rid="bib49">Moustafa et al., 2018</xref>). Genetics can affect the composition of the human gut microbiome (<xref ref-type="bibr" rid="bib23">Hall et al., 2017b</xref>). Additionally, IBD is associated with a variety of risk alleles that affect immune activation in response to microbial recognition and handling (<xref ref-type="bibr" rid="bib11">Davies and Abreu, 2015</xref>). Many studies have linked IBD to genetic risk variants in <italic>NOD2</italic> (<xref ref-type="bibr" rid="bib72">Turpin et al., 2018</xref>), which is involved in recognition of bacterial muramyl dipeptide, but one study has linked the presence of multiple NOD2 variants to increased levels of <italic>Enterobacteriaceae</italic> (<xref ref-type="bibr" rid="bib33">Knights et al., 2014</xref>). A single nucleotide polymorphism (SNP) in <italic>ATG16L1</italic> (re2241880, Thr300Ala) is associated with an increased risk of CD (<xref ref-type="bibr" rid="bib24">Hampe et al., 2007</xref>; <xref ref-type="bibr" rid="bib59">Rioux et al., 2007</xref>). ATG16L1 functions in autophagy, a cellular recycling system that aids in the sequestration of intracellular bacteria (<xref ref-type="bibr" rid="bib9">Cooney et al., 2010</xref>; <xref ref-type="bibr" rid="bib70">Travassos et al., 2010</xref>). <italic>ATG16L1</italic> hypomorphic mice have defects in anti-microbial peptide secretion by Paneth cells (<xref ref-type="bibr" rid="bib5">Cadwell et al., 2008</xref>) and <italic>ATG16L1</italic>-deficient macrophages show increased secretion of pro-inflammatory cytokines (<xref ref-type="bibr" rid="bib63">Saitoh et al., 2008</xref>). Conditional deletion of <italic>ATG16L1</italic> specifically in epithelial cells reduces autophagy and renders mice more susceptible to <italic>Salmonella enterica</italic> serovar Typhimurium infection and systemic translocation (<xref ref-type="bibr" rid="bib8">Conway et al., 2013</xref>). The Thr300Ala (T300A) variant displays enhanced degradation via active caspase 3 resulting in a reduction in the levels of ATG16L1 protein and reduced levels of autophagic flux (<xref ref-type="bibr" rid="bib50">Murthy et al., 2014</xref>; <xref ref-type="bibr" rid="bib39">Lassen et al., 2014</xref>). Moreover, microbial signatures are associated with variants in the gene for NOD2 (<xref ref-type="bibr" rid="bib74">Xavier and Podolsky, 2007</xref>), which interacts with ATG16L1 (<xref ref-type="bibr" rid="bib65">Sartor, 2008</xref>). T300A knock-in mice display defects in Paneth cells and goblet cells (<xref ref-type="bibr" rid="bib39">Lassen et al., 2014</xref>). More recently, T300A has been shown to directly affect lysozyme secretion from Paneth cells in mice in the context of infection (<xref ref-type="bibr" rid="bib3">Bel et al., 2017</xref>). These data suggest that T300A may play a role in shaping the response to gut microbes. Specifically, this may occur by loss of autophagy due to enhanced degradation of ATG16L1 T300A and altered anti-microbial peptide secretion. These effects in turn may affect microbial composition. While many of these studies have observed differences in mice in the context of infection, the effect of T300A on microbial composition has not been addressed. Furthermore, while these data suggest that alterations in the makeup of gut microbial communities may arise from the presence of certain risk alleles and may shape the downstream immune response; this has yet to be formally demonstrated.</p><p>A dysfunctional response to the microbiota can lead to adaptive immune cell infiltration in the gut during colitis (<xref ref-type="bibr" rid="bib15">Feng et al., 2010</xref>; <xref ref-type="bibr" rid="bib42">Lodes et al., 2004</xref>) and is a key contributor to disease pathology. Initially, studies suggested a role for Th1 cells in CD (<xref ref-type="bibr" rid="bib54">Parronchi et al., 1997</xref>) whereas Th2 cells were viewed as responsible for inflammation in UC (<xref ref-type="bibr" rid="bib28">Inoue et al., 1999</xref>). However, a more nuanced understanding of the role of T cells in IBD has lead to the implication of Th17 cells in CD pathogenesis as well. Th17 cells are characterized by the expression of the transcription factor RORγt<sup>+</sup> and produce high levels of the cytokines IL-17 and IL-22. High levels of these cytokines have been found in the gut mucosa of CD patients as compared to healthy controls (<xref ref-type="bibr" rid="bib17">Fujino et al., 2003</xref>; <xref ref-type="bibr" rid="bib2">Andoh et al., 2005</xref>). More recently, IFN-γ, a Th1 cell cytokine, IL-17 and IL-22 have been shown to be increased in the affected ileum compared to the uninfected ileum of CD patients (<xref ref-type="bibr" rid="bib40">Li et al., 2017</xref>). Because it is still unclear whether dysbiosis precedes inflammation, the initiation of an adaptive response to the gut microbiota in IBD still needs to be fully elucidated. Herein, we have utilized 16S rRNA gene amplicon sequencing, shotgun metagenomic sequencing, and analysis of immune cell populations in the gut to demonstrate that the risk allele T300A affects gut microbial composition in mice, both during inflammation under conventional housing conditions, and also in gnotobiotically-housed mice that harbor microbial communities derived from stool specimens from IBD patients, or in mice associated with <italic>Bacteroides ovatus</italic> with a limited, defined microbial community. Furthermore, we have shown that these differences can affect the immune response in the gut lamina propria (LP) prior to the manifestation of disease.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>T300A conventionally-housed specific-pathogen-free (SPF) mice display altered gut microbial composition at steady state</title><p>Previous studies have shown that IBD risk alleles can affect microbial composition (<xref ref-type="bibr" rid="bib33">Knights et al., 2014</xref>). Because ATG16L1 is involved in the handling of intracellular bacteria, we asked whether the IBD risk allele T300A could affect the gut microbiota in conventionally-housed SPF wild type (WT) vs. T300A knockin mice (<xref ref-type="bibr" rid="bib39">Lassen et al., 2014</xref>) at steady state. We conducted 16S rRNA gene amplicon surveys on stool samples from WT and T300A mice (<xref ref-type="fig" rid="fig1">Figure 1</xref>). We observed overall alterations in the microbiota of T300A mice compared to WT mice (<xref ref-type="fig" rid="fig1">Figure 1a</xref>). WT and T300A mice showed distinct separation by t-distributed stochastic neighbor embedding (t-SNE) analysis (<xref ref-type="fig" rid="fig1">Figure 1b</xref>) and we saw an increase in the order Bacteroidales (<xref ref-type="fig" rid="fig1">Figure 1c</xref>). Overall, these data suggest that T300A mice have alterations in the gut microbiota at steady state and that the abundance of the order Bacteroidales may be influenced by the presence of the T300A IBD risk allele in mice.</p><fig id="fig1" position="float"><object-id pub-id-type="doi">10.7554/eLife.39982.003</object-id><label>Figure 1.</label><caption><title>Altered microbiota in conventionally-housed WT vs T300A mice.</title><p>12 week old WT and T300A mice were conventionally-housed in a specific pathogen free (SPF) facility. Stool samples were collected and analyzed by 16S rRNA gene amplicon sequencing. (<bold>a</bold>) Population analysis of 16S rRNA gene amplicon sequencing from stool samples from SPF WT vs. T300A mice. (p = phylum, c = class, o = order, f = family, g = genus, s = species) Bacteria Z-scores generated by limma. (<bold>b</bold>) t-Distributed Stochastic Neighbor Embedding (tSNE) plot analysis of WT vs. T300A SPF mouse stool samples. (<bold>c</bold>) Box plot analysis of the order Bacteroidales in WT vs. T300A SPF mouse stool samples.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-39982-fig1-v1.tif"/></fig></sec><sec id="s2-2"><title>T300A conventionally-housed mice display altered gut microbial composition and an increased abundance of bacteroidetes including <italic>Bacteroides ovatus</italic> during gut inflammation</title><p>Given that the alterations observed in the human gut IBD microbiota are often studied in the context of gut inflammation and injury, we sought to determine whether the T300A allele would influence the gut microbiota in mice during a state of large intestinal injury and inflammation modeled using a chemical-based perturbation, as T300A mice do not spontaneously develop intestinal inflammation. We treated WT and T300A mice with 2.5% dextran sulfate sodium (DSS) in the drinking water for 7 days followed by 7 days of regular drinking water. We conducted 16S rRNA gene amplicon surveys on stool specimens after this two-week intervention from WT and T300A mice (<xref ref-type="fig" rid="fig2">Figure 2</xref>). We observed a decrease in the phylum Firmicutes and an increase in the phyla Bacteroidetes, Proteobacteria, and Cyanobacteria in T300A mice as compared to WT mice (<xref ref-type="fig" rid="fig2">Figure 2a</xref>). The microbiota of WT mice separated from cage-matched T300A mice by t-distributed stochastic neighbor embedding (t-SNE) analysis (<xref ref-type="fig" rid="fig2">Figure 2b</xref>). These data support that T300A plays a role in shaping the gut microbiota in the context of intestinal injury and recovery. When we looked specifically at the phyla Bacteroidetes, there was an increased abundance in T300A mice compared to WT mice (<xref ref-type="fig" rid="fig2">Figure 2c</xref>) suggesting that the T300A risk allele may specifically enhance <italic>Bacteroides spp</italic>. In particular, <italic>B. ovatus</italic> was increased significantly in T300A mice (<xref ref-type="fig" rid="fig2">Figure 2d</xref>). We analyzed the data using PICRUSt in order to infer metabolic function and found increased glycosaminoglycan degradation in samples from T300A mice (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>), a process which is uniquely attributed to Bacteroidetes (<xref ref-type="bibr" rid="bib35">Koropatkin et al., 2012</xref>). The degradation of glycosaminoglycans by Bacteroidetes has the potential to affect gut barrier function by reducing the thickness and integrity of the mucus layer and in turn contributes to bacterial translocation and host immune system activation. This observation has implications for the mechanism by which increased abundance of Bacteroidetes can contribute to disease pathogenesis in IBD. Additionally, we also observed increased weight loss in T300A mice from day 8 through 13 following treatment with DSS compared to WT mice, suggesting that these alterations in the microbiota are associated with heightened disease susceptibility (<xref ref-type="fig" rid="fig2">Figure 2e</xref>).</p><fig-group><fig id="fig2" position="float"><object-id pub-id-type="doi">10.7554/eLife.39982.004</object-id><label>Figure 2.</label><caption><title>Altered microbiota in conventionally-housed WT vs T300A mice with gut inflammation.</title><p>12 week old WT and T300A conventionally-housed SPF mice were treated with 2.5% DSS for 7d followed by 7d of regular drinking water. (<bold>a</bold>) Population analysis of 16S rRNA gene amplicon sequencing from stool samples from WT vs. T300A mice. (p = phylum, c = class, o = order, f = family, g = genus, s = species) Bacteria Z-scores generated by limma. (<bold>b</bold>) t-Distributed Stochastic Neighbor Embedding (tSNE) plot analysis of WT vs. T300A stool samples post DSS treatment. (<bold>c</bold>) Box plot analysis of the phylum Bacteroidetes in WT vs. T300A mice post DSS treatment. (<bold>d</bold>) Box plot analysis of <italic>B. ovatus</italic> in WT vs. T300A mice post DSS treatment. (<bold>e</bold>) Percent initial body weight of WT (n = 12) and T300A (n = 15) mice treated with 2.5% DSS for 7d followed by 7d of regular drinking water. Day 8–13 time points, p = &lt; 0.0001. Two-way ANOVA with Tukey‘s post-hoc test.</p><p><supplementary-material id="fig2sdata1"><object-id pub-id-type="doi">10.7554/eLife.39982.006</object-id><label>Figure 2—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig2">Figure 2</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-39982-fig2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-39982-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.39982.005</object-id><label>Figure 2—figure supplement 1.</label><caption><title>T300A affects the microbiome gene function profile.</title><p>Significant alterations in gene function inferred from 16S rRNA gene amplicon sequencing data using PICRUSt from stool samples obtained from 12 wk old WT versus T300A conventionally-housed SPF mice treated with 2.5% DSS followed by 7d regular drinking water.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-39982-fig2-figsupp1-v1.tif"/></fig></fig-group></sec><sec id="s2-3"><title>Human stool donor disease status shapes gut microbiota composition in mice</title><p>Next, we sought to determine whether the differences observed in the microbial community in T300A conventionally-housed mice during inflammation were specific to the mouse microbiome or whether the host T300A genotype could also influence the composition of donor human stool. We obtained a limited number of human stool samples from patients with a genotype of WT or T300A and with active or inactive disease status to associate germ-free (GF) mice. It should be noted that the T300A allele is a relatively common mutation in healthy individuals (<xref ref-type="bibr" rid="bib24">Hampe et al., 2007</xref>), thus our healthy control is heterozygous for T300A based on the availability of stool samples. First, to verify that patient stool samples would maintain a composition based on human donor disease status within the mouse gut, we orally inoculated WT and/or T300A gnotobiotically-housed mice with stool samples from two CD patients in remission (donor genotype T300A or WT, termed ‘inactive CD’), a CD patient with active inflammation (genotype T300A, termed ‘active CD’), an ulcerative colitis (UC) patient with active inflammation (genotype T300A, termed ‘active UC’), or a healthy volunteer (genotype heterozygous T300A (AG), termed ‘healthy control’) (<xref ref-type="fig" rid="fig3">Figure 3a</xref>). We compared the phylogenetic compositions from 16S rRNA gene amplicon sequencing data from the original human donor stool samples with phylogenetic composition analyses from our shotgun metagenomic data using MetaPhlAn from stool samples from GF mice associated with the indicated human stool samples. We observed that samples from these mice maintained diversity based on patient disease status by PCA analysis (<xref ref-type="fig" rid="fig3">Figure 3a</xref>). Individual mice associated with the same patient stool clustered together with the original samples from human donor samples used for the GF associations. This observation suggested that the differences in the human microbiome from patient samples were maintained within the mouse gut.</p><fig id="fig3" position="float"><object-id pub-id-type="doi">10.7554/eLife.39982.007</object-id><label>Figure 3.</label><caption><title>Distinct gut microbiota composition in mice associated with human stool.</title><p>GF mice were associated with human stool samples and analyzed after four wks. (<bold>a</bold>) tSNE dimensionality reduction analysis based on genus-level abundances of stool samples from human patient stool donor (square) or GF WT (circles) and T300A (triangles) mice four wks post association with 50 mg human stool from patients: healthy control, genotype Het (yellow), inactive CD, genotype WT (blue), inactive CD, genotype T300A (green), active CD, genotype T300A (red), or active UC, genotype T300A (purple). Each symbol represents data from an individual mouse. (<bold>b</bold>) PCA plot of stool samples from WT vs. T300A mice four wks post association with either active CD (left) or active UC (right) human stool. Each symbol represents data from an individual mouse.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-39982-fig3-v1.tif"/></fig></sec><sec id="s2-4"><title>T300A alters gut microbiota composition in gnotobiotically-housed mice associated with active CD stool</title><p>To determine whether the presence of T300A could alter the gut microbiota, we orally inoculated human stool from individual IBD patients with active disease (one with CD or one with UC) into gnotobiotically-housed WT or T300A mice. Four weeks after oral inoculation, we assessed the stool microbial composition by metagenomic sequencing and MetaPhlAn followed by PCA analysis (<xref ref-type="fig" rid="fig3">Figure 3b</xref>). We observed a difference in WT vs. T300A mice by PCA in mice that received stool from a CD patient with active disease but not in mice inoculated with stool from a UC patient with active disease (<xref ref-type="fig" rid="fig3">Figure 3b</xref>). These data suggest that differences in the active CD microbiota in mice are due to the presence of the risk allele T300A as opposed to microbial population drift due to human stool transfer into mice alone. When we examined the microbial composition of WT vs. T300A mice associated with stool from IBD patients with active disease, we observed an increase in the genus <italic>Bacteroides</italic> in T300A mice that received stool from patients with active CD as compared to WT mice (<xref ref-type="fig" rid="fig4">Figure 4a</xref>). <italic>B. ovatus</italic> was also increased in T300A mice that received stool from patients with active CD (<xref ref-type="fig" rid="fig4">Figure 4b</xref>), further supporting the idea that T300A has the potential to drive increases in <italic>Bacteroides spp</italic>. We did observe high levels of <italic>Bacteroides</italic> in mice that received stool from patients with active UC but no significant difference between WT and T300A mice (<xref ref-type="fig" rid="fig4">Figure 4b</xref>). We did not see major significant changes to the microbiota in WT vs. T300A mice associated with active UC stool. These data suggest that the human CD microbiota may be more susceptible to the presence of T300A, driving larger differences in microbial populations compared to mice associated with stool from patients with active UC.</p><fig id="fig4" position="float"><object-id pub-id-type="doi">10.7554/eLife.39982.008</object-id><label>Figure 4.</label><caption><title>T300A alters gut microbiota composition in GF mice associated with human stool.</title><p>Metagenomic population analysis (MetaPhlAn) on stool samples (four wk time point) from WT vs. T300A GF mice associated with human IBD stool samples (<bold>a</bold>) Box plot of the genus <italic>Bacteroides</italic> from stool samples from mice associated with active CD or active UC stool samples. (<bold>b</bold>) Box plot of <italic>B. ovatus</italic> from stool samples from mice associated with active CD or active UC stool samples. P-values were generated using Benjamini-Hochberg false discovery rate. (<bold>a, b</bold>) Y-axis is log10 relative abundance.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-39982-fig4-v1.tif"/></fig></sec><sec id="s2-5"><title>Presence of T300A in humans increases <italic>Bacteroides</italic></title><p>Previous reports on the abundance of Bacteroidetes show conflicting results in humans (<xref ref-type="bibr" rid="bib25">Hold et al., 2014</xref>), with some studies reporting an increased abundance while others report a decreased abundance in patients with IBD. Therefore, we investigated whether the increase in <italic>Bacteroides</italic> in the microbiota of T300A mice was also seen in IBD patients with the risk allele T300A (<xref ref-type="fig" rid="fig5">Figure 5</xref>). We utilized patient genotype data and stool microbiome data available from a previous study (<xref ref-type="bibr" rid="bib29">Jostins et al., 2012</xref>). When we compared the microbiota from IBD patients with WT (AA) genotype versus heterozygous patients (AG) versus T300A (GG) genotype, we saw a trend toward an increase in the genus <italic>Bacteroides</italic> (<xref ref-type="fig" rid="fig5">Figure 5a</xref>). We also observed a trend toward an increase in the <italic>B. fragilis</italic> group (<xref ref-type="fig" rid="fig5">Figure 5b</xref>) and a significant increase in the species <italic>Bacteroides caccae</italic> (<xref ref-type="fig" rid="fig5">Figure 5c</xref>). In contrast, we observed a decrease in <italic>Clostridia</italic> and an increase in <italic>Gammaproteobacteria</italic> (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>) both of which have been observed in numerous human IBD studies (<xref ref-type="bibr" rid="bib16">Frank et al., 2007</xref>; <xref ref-type="bibr" rid="bib20">Gophna et al., 2006</xref>; <xref ref-type="bibr" rid="bib58">Rehman et al., 2010</xref>) and pre-clinical colitis models (<xref ref-type="bibr" rid="bib61">Rooks et al., 2014</xref>; <xref ref-type="bibr" rid="bib19">Garrett et al., 2010b</xref>). These data show that the presence of T300A has the potential to reconfigure the human microbiota and that the presence of a heterozygous genotype displays an intermediate phenotype with <italic>Bacteroides spp,</italic> suggesting that even a mild alteration in ATG16L1 can have an effect on bacterial abundance. This association of the risk allele T300A and alterations in the microbiota have not previously been described. This link between genotype and gut microbial phenotype in humans is important for furthering our understanding of the basis of IBD pathogenesis. Whether or not genotype and the microbiota are also associated with differences in immune populations in humans, prior to IBD disease onset or recrudescence is yet to be determined.</p><fig-group><fig id="fig5" position="float"><object-id pub-id-type="doi">10.7554/eLife.39982.009</object-id><label>Figure 5.</label><caption><title>The presence of T300A in humans increases <italic>Bacteroides</italic>.</title><p>16S rRNA gene amplicon data from human stool samples from Jostins et al. 2012 (<xref ref-type="bibr" rid="bib29">Jostins et al., 2012</xref>) cohort were analyzed for differences in the microbiota associated with the presence (T300A – GG), absence (WT – AA) or heterozygous (Het – AG) genotype. (g = genus, s = species). (<bold>a</bold>) Relative abundance of <italic>Bacteroides</italic>. (<bold>b</bold>) Relative abundance of <italic>B. fragilis</italic>. (<bold>c</bold>) Relative abundance of <italic>B. caccae</italic>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-39982-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.39982.010</object-id><label>Figure 5—figure supplement 1.</label><caption><title>The presence of T300A in humans reduces <italic>Clostrida spp</italic>. and increases <italic>Gammaproteobacteria.</italic></title><p>16S rRNA gene amplicon data from human stool samples from Jostins et al. 2012 (<xref ref-type="bibr" rid="bib74">Xavier and Podolsky, 2007</xref>) cohort were analyzed for differences in the microbiota associated with the presence (T300A – GG), absence (WT – AA) or heterozygous (Het – AG) genotype. (g = genus). (<bold>a</bold>) Relative abundance of <italic>Roseburia</italic>. (<bold>b</bold>) Relative abundance of <italic>Blautia</italic>. (<bold>c</bold>) Relative abundance of <italic>Oscillospira</italic>. (<bold>d</bold>) Relative abundance of <italic>Haemophilus</italic>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-39982-fig5-figsupp1-v1.tif"/></fig></fig-group></sec><sec id="s2-6"><title>T300A selectively alters gut immune cell populations in mice associated with active CD patient stool</title><p>We sought to discern whether the alterations we observed in the gut microbiota of T300A mice were also associated with changes in immune cell populations in the gut of gnotobiotic WT versus T300A mice associated with patient stool. Crohn’s disease has been linked to an increase in both Th17 cells and Th1 cells in the gut (<xref ref-type="bibr" rid="bib54">Parronchi et al., 1997</xref>; <xref ref-type="bibr" rid="bib17">Fujino et al., 2003</xref>; <xref ref-type="bibr" rid="bib2">Andoh et al., 2005</xref>; <xref ref-type="bibr" rid="bib40">Li et al., 2017</xref>). Th17 and Th1 cells are characterized by the expression of the transcription factors RORγt and T-bet respectively. Therefore, we analyzed RORγt<sup>+</sup> (Th17) and T-bet<sup>+</sup> (Th1) T cells in addition to Foxp3<sup>+</sup> regulatory T cells (Treg), as well as GATA-3<sup>+</sup> (Th2) cells by flow cytometry from mice associated with stool from patients with active CD or active UC (<xref ref-type="fig" rid="fig6">Figure 6</xref>). T cells were gated as the frequency of CD3<sup>+</sup>CD4<sup>+</sup>, live, CD45<sup>+</sup>, lymphocytes (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>). Myeloid cells can also play a role in inflammation during IBD, and loss of ATG16L1 in myeloid and dendritic cells leads to enhanced colitis and increased production of inflammatory cytokines (<xref ref-type="bibr" rid="bib76">Zhang et al., 2017</xref>). Thus, we analyzed the following myeloid cell populations: CD11c<sup>+</sup>MHCII<sup>+</sup> conventional dendritic cells (DCs), CD11b<sup>-</sup>CD103<sup>+</sup> tolerogenic DCs, CD11b<sup>+</sup>GR-1<sup>int</sup> neutrophils, and CD11b<sup>+</sup>GR-1<sup>hi</sup> inflammatory monocytes by flow cytometry (<xref ref-type="fig" rid="fig6">Figure 6</xref>). Conventional DCs, neutrophils and inflammatory monocytes were gated out of live, CD45<sup>+</sup> cells and tolerogenic DCs were gated out of conventional DCs (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2</xref>). We examined the frequency of T cell populations and myeloid cell populations in the lamina propria (LP) of the colon and ileum from WT and T300A mice associated with stool from patients with either active CD or active UC (<xref ref-type="fig" rid="fig6">Figure 6</xref>). We observed increased frequencies of Th17 and Th1 T cells exclusively in the LP of the colon and ileum from T300A mice that received stool from patients with active CD (<xref ref-type="fig" rid="fig6">Figure 6a and c</xref>) and not in the LP of the colon or ileum of mice that received stool from patients with active UC (<xref ref-type="fig" rid="fig6">Figure 6b and d</xref>). These data support an association between alterations in the gut microbiota driven by the risk allele T300A and increased frequencies of Th17 and Th1 T cells in the gut LP. We also found an increase in the frequency of Tregs in the LP of the colon from T300A mice associated with stool from patients with CD (<xref ref-type="fig" rid="fig6">Figure 6a</xref>) and a minor increase in the ileum in T300A mice associated with stool from patients with UC (<xref ref-type="fig" rid="fig6">Figure 6d</xref>). The only differences we observed in myeloid cells occurred in the LP of the colon from mice associated with stool from patients with active CD (<xref ref-type="fig" rid="fig6">Figure 6a</xref>). We saw a reduced frequency of conventional DCs and a slight increase in the frequency of tolerogenic DCs along with a decrease in neutrophils and inflammatory monocytes in T300A mice (<xref ref-type="fig" rid="fig6">Figure 6a</xref>). Why some of these populations are reduced is yet to be determined. Overall these data suggest that the presence of the T300A allele in mice can enhance Th17 and Th1 cells in the LP of the colon and ileum and alter the frequency of DCs, neutrophils, and inflammatory monocytes in the presence of stool from patients with active CD. It should be noted that histology-based grading of the colon and small intestine from mice associated with human IBD stool showed no signs of colitis, enteritis, or any intestinal histopathology (<xref ref-type="fig" rid="fig6s3">Figure 6—figure supplement 3</xref>). This suggests that an alteration in the microbiota composition and alterations in gut immune cells occur before the onset of disease as assessed by histology. Whether specific microbes are responsible for differences in individual subsets of immune cells in the absence of disease is not well understood.</p><fig-group><fig id="fig6" position="float"><object-id pub-id-type="doi">10.7554/eLife.39982.011</object-id><label>Figure 6.</label><caption><title>Alterations in T cell and myeloid cell populations in the gut of T300A mice associated with stool from patients with active Crohn’s disease.</title><p>LP flow cytometry of T and myeloid cell populations from GF mice associated with 50 mg of frozen stool from a patient with Crohn’s disease (CD, WT <italic>n</italic> = 6 and T300A <italic>n</italic> = 6) or ulcerative colitis (UC, WT <italic>n</italic> = 7 and T300A <italic>n</italic> = 5) for four wks. T cells gated as the frequency of RORγt<sup>+</sup> (Th17), T-bet<sup>+</sup> (Th1), Foxp3<sup>+</sup> (Treg) or GATA-3<sup>+</sup> (Th2) cells out of CD3<sup>+</sup>CD4<sup>+</sup> cells and myeloid cells gated as the frequency of CD11c<sup>+</sup>MHCII<sup>+</sup> cells out of CD45<sup>+</sup> cells (conventional DCs), CD11b<sup>-</sup>CD103<sup>+</sup> cells out of CD11c<sup>+</sup>MHCII<sup>+</sup> cells (tolerogenic DCs), CD11b<sup>+</sup>GR-1<sup>int</sup> cells out of CD45<sup>+</sup> cells (neutrophils), and CD11b<sup>+</sup>GR-1<sup>hi</sup> cells out of CD45<sup>+</sup> cells (inflammatory monocytes). CD3<sup>+</sup>CD4<sup>+</sup> and myeloid cell populations were gated on single, live, CD45<sup>+</sup> lymphocytes. (<bold>a</bold>) GF +CD stool colonic LP T cells (top) and myeloid cells (bottom) (<bold>b</bold>) GF +UC stool colonic LP T cells (top) and myeloid cells (bottom). (<bold>c</bold>) GF +CD stool ileal LP T cells (top) and myeloid cells (bottom) (<bold>d</bold>) GF +UC stool ileal LP T cells (top) and myeloid cells (bottom). Data are plotted as the mean ± SEM. ns = not significant. Mann-Whitney <italic>U</italic> test.</p><p><supplementary-material id="fig6sdata1"><object-id pub-id-type="doi">10.7554/eLife.39982.015</object-id><label>Figure 6—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig6">Figure 6</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-39982-fig6-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-39982-fig6-v1.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.39982.012</object-id><label>Figure 6—figure supplement 1.</label><caption><title>Representative T cell flow cytometry gating strategy.</title><p>LP cells from either the colon or ileum (distal 10 cm of the small intestine) were gated on single cells, live cells, CD45<sup>+</sup>, lymphocytes, CD3<sup>+</sup>CD4<sup>+</sup> and finally T-bet<sup>+</sup> out of CD3<sup>+</sup>CD4<sup>+</sup> and RORγt<sup>+</sup> out of CD3<sup>+</sup>CD4<sup>+</sup>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-39982-fig6-figsupp1-v1.tif"/></fig><fig id="fig6s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.39982.013</object-id><label>Figure 6—figure supplement 2.</label><caption><title>Representative myeloid cell flow cytometry gating strategy.</title><p>LP cells from either the colon or ileum (distal 10 cm of the small intestine) were gated on single cells, live cells and CD45<sup>+</sup>. CD11c<sup>+</sup>MHCII<sup>+</sup> (1 - conventional DCs) were gated out of CD45<sup>+</sup> cells and CD11b<sup>-</sup>CD103<sup>+</sup> cells (2 - tolerogenic DCs) were gated out of CD11c<sup>+</sup>MHCII<sup>+</sup> cells. CD11b<sup>+</sup>GR-1<sup>hi</sup> (3 - inflammatory monocytes) and CD11b<sup>+</sup>GF-1<sup>int</sup> (4 - neutrophils) were gated out of CD45<sup>+</sup>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-39982-fig6-figsupp2-v1.tif"/></fig><fig id="fig6s3" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.39982.014</object-id><label>Figure 6—figure supplement 3.</label><caption><title>Microbiota changes and immune infiltration occur in the absence of disease.</title><p>WT and T300A gnotobiotically housed mice were associated with human stool samples from patients with either active CD (WT n = 6, T300A n = 6) or active UC (WT n = 7, T300A n = 5). Histologic colitis/ileitis scores were calculated by grading monocyte infiltration, epithelial hyperplasia, epithelial injury and polymorphonuclear (PMN) cell infiltration, all from 0 to 3 for a maximum total score of 12. Histologic colitis scores from (<bold>a</bold>) the colon and (<bold>b</bold>) the ileum from mice associated with stool from patients with active CD or active UC. Data are plotted as mean ± SEM.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-39982-fig6-figsupp3-v1.tif"/></fig></fig-group></sec><sec id="s2-7"><title>T300A selectively enhances Th17 cells in the gut of mice with a restricted, defined microbiota in the presence of <italic>Bacteroides ovatus</italic></title><p>Previous studies support that <italic>Bacteroides spp</italic>. can drive a Th17 response in the colon (<xref ref-type="bibr" rid="bib69">Tan et al., 2016</xref>), suggesting that the increase we observe in Th17 cells in the LP of the colon from T300A mice could be driven by the increase in <italic>Bacteroides</italic> in these mice (see <xref ref-type="fig" rid="fig4">Figure 4</xref>). Therefore, we assessed whether the presence of <italic>B. ovatus,</italic> a species that we observed increased in abundance in T300A mice associated with active CD stool, would selectively alter gut immune populations in T300A mice. To test this hypothesis we associated GF and altered Schaedler flora (ASF), a restricted, defined microbial community of eight bacterial members, WT and T300A mice with ~10<sup>9</sup> CFU of <italic>B. ovatus</italic> 8483 for 3 weeks. Because it has been shown that housing of mice in separate cages can affect the composition of the gut microbiota, WT and T300A mice were co-housed during the association of all studies performed with <italic>B. ovatus</italic> 8483. Information on caging, age, and sex of mice for all studies can be found in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>. We found no difference in any immune populations in WT or T300A GF mice or GF mice associated solely with <italic>B. ovatus</italic> 8483 (<xref ref-type="fig" rid="fig7">Figure 7</xref>). However, T300A ASF mice showed an increase only in Th17 cells in the LP of the colon and ileum when <italic>B. ovatus</italic> 8483 was present (<xref ref-type="fig" rid="fig8">Figure 8b and d</xref>), but there was no difference in ASF mice in the absence of <italic>B. ovatus</italic> 8483 (<xref ref-type="fig" rid="fig8">Figure 8a and c</xref>). Besides a slight decrease in Th1 cells in the ileum of T300A ASF mice in the presence of <italic>B. ovatus</italic> 8483 (<xref ref-type="fig" rid="fig8">Figure 8d</xref>), there were no other changes in the immune populations analyzed. These data suggest that the presence of the T300A allele and additional members of the microbiota can increase the presence of Th17 cells in the gut. This increase in frequency of Th17 cells in T300A ASF mice with <italic>B. ovatus</italic> 8483 also occurred in the absence of colitis, enteritis, or any intestinal histopathology (<xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1</xref>), or differences in the level of colonization of WT and T300A mice with <italic>B. ovatus</italic> 8483 (<xref ref-type="fig" rid="fig8s2">Figure 8—figure supplement 2</xref>). This demonstrates that the differences in Th17 cells in ASF T300A <italic>B. ovatus</italic> 8483 mice were not due to an increase in colonization of <italic>B. ovatus</italic> but rather were most likely due to the presence of the T300A allele alone.</p><fig id="fig7" position="float"><object-id pub-id-type="doi">10.7554/eLife.39982.016</object-id><label>Figure 7.</label><caption><title>No change in immune cell population frequency in the gut of GF or GF mice monoassociated with <italic>B. ovatus</italic> 8483.</title><p>LP flow cytometry of T and myeloid cell populations from GF mice (WT <italic>n</italic> = 6, T300A <italic>n</italic> = 6) or GF mice associated with ~10<sup>9</sup> CFU of <italic>B. ovatus</italic> 8483 for three wks (WT <italic>n</italic> = 6, T300A <italic>n</italic> = 6). T cell populations are gated as the frequency of RORγt<sup>+</sup> (Th17), T-bet<sup>+</sup> (Th1), Foxp3<sup>+</sup> (Treg) or GATA-3<sup>+</sup> (Th2) cells out of CD3<sup>+</sup>CD4<sup>+</sup> cells and myeloid cell populations are gated as the frequency of CD11c<sup>+</sup>MHCII<sup>+</sup> cells out of CD45<sup>+</sup> cells (conventional DCs), CD11b<sup>-</sup>CD103<sup>+</sup> cells out of CD11c<sup>+</sup>MHCII<sup>+</sup> cells (tolerogentic DCs), CD11b<sup>+</sup>GR-1<sup>int</sup> cells out of CD45<sup>+</sup> cells (neutrophils), and CD11b<sup>+</sup>GR-1<sup>hi</sup> cells out of CD45<sup>+</sup> cells (inflammatory monocytes). CD3<sup>+</sup>CD4<sup>+</sup> and myeloid cell populations were gated on single, live, CD45<sup>+</sup> lymphocytes. (<bold>a</bold>) GF colonic LP T cells (top) and myeloid cells (bottom) (<bold>b</bold>) GF +<italic>B. ovatus</italic> 8483 colonic LP T cells (top) and myeloid cells (bottom). (<bold>c</bold>) GF ileal LP T cells (top) and myeloid cells (bottom) (<bold>d</bold>) GF +<italic>B. ovatus</italic> 8483 ileal LP T cells (top) and myeloid cells (bottom). Data are plotted as the mean ± SEM. ns = not significant. Mann-Whitney <italic>U</italic> test.</p><p><supplementary-material id="fig7sdata1"><object-id pub-id-type="doi">10.7554/eLife.39982.017</object-id><label>Figure 7—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig7">Figure 7</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-39982-fig7-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-39982-fig7-v1.tif"/></fig><fig-group><fig id="fig8" position="float"><object-id pub-id-type="doi">10.7554/eLife.39982.018</object-id><label>Figure 8.</label><caption><title>Increased frequency of Th17 cells in the gut of T300A ASF mice associated with <italic>B. ovatus</italic> 8483.</title><p>LP flow cytometry of T cell and myeloid cell populations from ASF mice (WT <italic>n</italic> = 6 and T300A <italic>n</italic> = 6) or ASF mice associated with ~10<sup>9</sup> CFU of <italic>B. ovatus</italic> 8483 for 3 weeks (WT <italic>n</italic> = 6 and T300A <italic>n</italic> = 6). T cells gated as the frequency of RORγt<sup>+</sup> (Th17), T-bet<sup>+</sup> (Th1), Foxp3<sup>+</sup> (Treg) or GATA-3<sup>+</sup> (Th2) cells out of CD3<sup>+</sup>CD4<sup>+</sup> cells and myeloid cell gated as the frequency of CD11c<sup>+</sup>MHCII<sup>+</sup> cells out of CD45<sup>+</sup> cells (conventional DCs), CD11b<sup>-</sup>CD103<sup>+</sup> cells out of CD11c<sup>+</sup>MHCII<sup>+</sup> cells (tolerogentic DCs), CD11b<sup>+</sup>GR-1<sup>int</sup> cells out of CD45<sup>+</sup> cells (neutrophils), and CD11b<sup>+</sup>GR-1<sup>hi</sup> cells out of CD45<sup>+</sup> cells (inflammatory monocytes). CD3<sup>+</sup>CD4<sup>+</sup> cell and myeloid cell populations were gated on single, live, CD45<sup>+</sup> lymphocytes. (<bold>a</bold>) ASF colonic LP T cells (top) and myeloid cells (bottom) (<bold>b</bold>) ASF +<italic>B. ovatus</italic> 8483 colonic LP T cells (top) and myeloid cells (bottom). (<bold>c</bold>) ASF ileal LP T cells (top) and myeloid cells (bottom) (<bold>d</bold>) ASF +<italic>B. ovatus</italic> 8483 ileal LP T cells (top) and myeloid cells (bottom). Data are plotted as the mean ± SEM. ns = not significant. Mann-Whitney <italic>U</italic> test.</p><p><supplementary-material id="fig8sdata1"><object-id pub-id-type="doi">10.7554/eLife.39982.021</object-id><label>Figure 8—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig8">Figure 8</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-39982-fig8-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-39982-fig8-v1.tif"/></fig><fig id="fig8s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.39982.019</object-id><label>Figure 8—figure supplement 1.</label><caption><title>Immune infiltration in ASF mice associated with <italic>B. ovatus</italic> occurs in the absence of disease.</title><p>WT and T300A ASF mice were associated ~10<sup>9</sup> CFU of <italic>B. ovatus</italic> 8483 for 3 weeks (WT n = 6, T300A n = 6). Histologic colitis/ileitis scores were calculated by grading monocyte infiltration, epithelial hyperplasia, epithelial injury and polymorphonuclear (PMN) cell infiltration, all from 0 to 3 for a maximum total score of 12. Histologic colitis/ileitis scores from (<bold>a</bold>) the colon and (<bold>b</bold>) the ileum of ASF mice or ASF mice associated with <italic>B. ovatus</italic> 8483. Data are plotted as mean ± SEM.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-39982-fig8-figsupp1-v1.tif"/></fig><fig id="fig8s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.39982.020</object-id><label>Figure 8—figure supplement 2.</label><caption><title>No differences in colonization levels of <italic>B. ovatus</italic> 8483 in GF or ASF mice.</title><p>GF mice (WT <italic>n</italic> = 6, T300A <italic>n</italic> = 6) or ASF mice (<italic>n</italic> = 6, T300A <italic>n</italic> = 6) were associated with ~10<sup>9</sup> CFU of <italic>B. ovatus</italic> 8483 for three wks. Fecal samples were taken at the three wk timepoint and CFU/g stool was calculated. ns = not significant. Two-way ANOVA with Tukey’s post-hoc test.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-39982-fig8-figsupp2-v1.tif"/></fig></fig-group></sec><sec id="s2-8"><title>The presence of <italic>Bacteroides ovatus</italic> increases the expression of <italic>Il23p19</italic> in T300A ASF mice</title><p>The increase in Th17 cells in the gut of T300A ASF mice associated with <italic>B. ovatus</italic> prompted us to look at expression levels of the IL-23 specific subunit, IL-23p19, in the LP of the colon and ileum from T300A mice (<xref ref-type="fig" rid="fig9">Figure 9</xref>). IL-23 induces IL-17 producing cells that can induce inflammation (<xref ref-type="bibr" rid="bib38">Langrish et al., 2005</xref>) and is essential for the production of IL-17 in T-cell mediated colitis (<xref ref-type="bibr" rid="bib75">Yen et al., 2006</xref>). Additionally, antibodies targeting IL-23 have been utilized as a treatment for IBD and antibodies specific for IL-23p19 show promising clinical trial results (<xref ref-type="bibr" rid="bib48">Moschen et al., 2018</xref>), suggesting that IL-23 plays an important role in IBD pathogenesis. We found that in T300A ASF mice, the presence of <italic>B. ovatus</italic> 8483 increased expression levels of <italic>Il23p19</italic> in the LP of both the colon (<xref ref-type="fig" rid="fig9">Figure 9a</xref>) and ileum (<xref ref-type="fig" rid="fig9">Figure 9b</xref>). Overall, these results demonstrate that the presence of <italic>B. ovatus</italic> 8483 in the context of the T300A allele and a minimal microbiota can enhance both IL-23 expression and Th17 cell infiltration into the gut before the onset of disease symptoms in mice.</p><fig id="fig9" position="float"><object-id pub-id-type="doi">10.7554/eLife.39982.022</object-id><label>Figure 9.</label><caption><title>Increased expression of <italic>Il23p19</italic> in the lamina propria from the colon and ileum of T300A ASF mice associated with <italic>B. ovatus</italic> 8483.</title><p>Expression of <italic>Il23p19</italic> by qPCR from colon (<bold>a</bold>) and ileum (<bold>b</bold>) LP cells isolated from ASF T300A mice or ASF T300A mice associated with <italic>B. ovatus</italic> 8483.</p><p><supplementary-material id="fig9sdata1"><object-id pub-id-type="doi">10.7554/eLife.39982.023</object-id><label>Figure 9—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig9">Figure 9</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-39982-fig9-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-39982-fig9-v1.tif"/></fig></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>The role of the gut microbiota in IBD pathogenesis is well established, but how and when microbial dysbiosis occurs during disease progression is less well understood. The identification of IBD genetic risk loci involved in the processing and handling of microbes provides more definitive clues into disease pathogenesis. However, we still do not fully understand how host genotype or particular SNPs influence microbial community assembly, community composition, or function. The reduced barrier integrity associated with defects in Paneth cell anti-microbial peptide secretion in T300A hypomorphic mice (<xref ref-type="bibr" rid="bib6">Cadwell et al., 2009</xref>) and T300A knock-in mice (<xref ref-type="bibr" rid="bib8">Conway et al., 2013</xref>), and increased production of inflammatory cytokines by ATG16L1 deficient innate immune cells in response to infiltrating bacteria (<xref ref-type="bibr" rid="bib63">Saitoh et al., 2008</xref>) can activate an adaptive immune response to the gut microbiota. However, whether genetic risk loci directly affect specific gut microbial population frequency is not known. Here we show that the presence of the CD risk allele <italic>ATG16L1 </italic>T300A in both mice and humans can shape the gut microbiota. More specifically, it can enhance the abundance of <italic>Bacteroides</italic>, including <italic>B. ovatus</italic>, as well as increase the local Th1 and Th17 response in the gut LP in T300A mice associated with stool from a patient with active CD but not stool from a patient with active UC.</p><p>We found that minimal microbiota ASF T300A mice associated with <italic>B. ovatus</italic> 8483, specifically increased Th17 cells, suggesting that the other differences we saw in Treg and myeloid cell populations in T300A mice associated with stool from a patient with active CD may be due to the presence of other species in the CD microbiota. While we observe increases in other microbial populations, including Proteobacteria and Cyanobacteria in conventional-housed T300A subjected to chemically-induced inflammatory conditions, the increase in Bacteroidetes was common between both DSS-treated conventionally-housed mice and gnotobiotically-reared human stool associated mice, suggesting that T300A could potentially be a driver of increased Th17 and Th1 T cell populations in the gut LP via increased <italic>Bacteroides spp</italic>. When T300A ASF mice were associated with <italic>B. ovatus</italic> 8483, we did not observe differences in levels of colonization, suggesting that the increase in the frequency of Th17 T cells in the gut LP was independent of the level of colonization. Why we did not find differences in immune populations in GF WT and T300A mice monocolonized with <italic>B. ovatus</italic> 8483 is intriguing as it suggests that this increase in Th17 cells requires the presence of a more complex microbiota. Future work will be needed to elucidate how the immune response to <italic>B. ovatus</italic> changes in the presence of additional microbial species and in the context of distinct host genotypes associated with IBD. Specifically, what is the nature of the co-occurrence relationships between <italic>B. ovatus</italic> and other members of a microbiota necessary for Th17 T cell expansion? Alternatively, are there a series of one-on-one host-microbe relationships in tandem or sequentially that are required for Th17 T cell expansion in the LP of the colon and ileum?</p><p>Previous studies have demonstrated the ability of individual <italic>Bacteroides spp</italic>. to induce IBD in genetically susceptible mice (<xref ref-type="bibr" rid="bib4">Bloom et al., 2011</xref>) and others have shown that <italic>Bacteroides spp</italic>. can induce IL-17 response in the gut (<xref ref-type="bibr" rid="bib69">Tan et al., 2016</xref>). Exactly how T300A could enhance <italic>Bacteroides</italic> specifically is yet to be determined. We found that expression of a subunit of IL-23, <italic>Il23p19,</italic> a cytokine known to increase IL-17 production from T cells, was increased in both the LP of the colon and the ileum from T300A mice associated with <italic>B. ovatus</italic> 8483. Other studies have shown that <italic>B. fragilis</italic> enterotoxin can induce formation of autophagosomes (<xref ref-type="bibr" rid="bib34">Ko et al., 2017</xref>). Another report demonstrated that ATG16L1 is required to generate a regulatory T cell response to <italic>B. fragilis</italic> outer membrane vesicles (<xref ref-type="bibr" rid="bib7">Chu et al., 2016</xref>). Because T300A is susceptible to caspase 3 cleavage and is preferentially targeted for degradation compared to WT ATG16L1 (<xref ref-type="bibr" rid="bib72">Turpin et al., 2018</xref>), reduced xenophagy levels could allow for an outgrowth of <italic>Bacteroides</italic>, and an insufficient regulatory T cell response necessary to dampen Th17 population expansion. ATG16L1 and Nod2 (another CD risk allele) have been shown to interact in an autophagy-dependent antibacterial pathway (<xref ref-type="bibr" rid="bib26">Homer et al., 2010</xref>), suggesting that defects in either pathway could affect <italic>Bacteroides</italic> abundance. For example, Nod2 is essential for preventing the expansion of <italic>Bacteroides vulgatus</italic> in mice (<xref ref-type="bibr" rid="bib57">Ramanan et al., 2014</xref>). We also saw that T300A in humans was associated with a trend in increased levels of <italic>Bacteroides</italic> including the <italic>B. fragilis</italic> group and a significant increase in <italic>B. caccae</italic> which is closely related to <italic>B. ovatus</italic> (<xref ref-type="bibr" rid="bib64">Sakamoto and Ohkuma, 2011</xref>). An intermediate phenotype was seen in people with the heterozygous (AG) genotype. More research, especially in a prospective cohort of at-risk individuals, will be needed to determine whether IBD patients with T300A have an increase in <italic>B. ovatus</italic> prior to disease onset and whether this contributes to disease pathogenesis.</p><p>IBD symptoms can vary in nature and severity as well as disease location. While some patients will respond to treatment, others will not, suggesting that subtypes of the disease may be dependent on both genetics and the microbiota. Healthy individuals and CD patients may harbor multiple risk alleles, compounding the effect of specific alleles on the microbiota, and further studies will be needed to address the complexity of genetic associations with gut microbial composition. However, understanding how risk alleles can shape both the microbiota and the underlying immune response, in tandem, can provide insight into identifying subsets of the disease as well as inform diagnosis and treatment decisions. We have shown that the risk allele <italic>ATG16L1 </italic>T300A, a SNP associated with an increased risk of CD, contributes to dysbiosis in mice, specifically an increase in <italic>Bacteroides</italic> among other alterations, and correlates with an enhanced Th1 and Th17 immune response in the gut LP. These changes precede the onset of disease in human stool microbiome associated mice, suggesting that microbiota changes induce inflammatory cell population shifts in the gut. These results shed light on the etiology of CD and provide insight into the relationship between SNPs, dysbiosis and the immune response in the gut.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th valign="top">Reagent type (species) <break/>or resource</th><th valign="top">Designation</th><th valign="top">Source or <break/>reference</th><th valign="top">Identifiers</th><th valign="top">Additional information</th></tr></thead><tbody><tr><td valign="top">Genetic reagent (<italic>M. musculus</italic>)</td><td valign="top">T300A</td><td valign="top">PMID: 24821797</td><td valign="top"/><td valign="top">Dr. Ramnik Xavier (Broad/MIT/Harvard)</td></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Dextran Sulfate Sodium</td><td valign="top">MP Biomedicals</td><td valign="top">0216011050–50 g</td><td valign="top"/></tr><tr><td valign="top">, strain back ground</td><td valign="top"><italic>Bacteroides ovatus</italic></td><td valign="top">ATCC</td><td valign="top">8483</td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Picard suite</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://broadinstitute.github.io/picard/command-line-overview.html">https://broadinstitute.github.io/picard/command-line-overview.html</ext-link></td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_006525">SCR_006525</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">MetaPhlAn</td><td valign="top">PMID 26418763</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_004915">SCR_004915</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">HUMAnN2</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="http://huttenhower.sph.">http://huttenhower.sph.</ext-link> harvard.edu/humann2</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_016280">SCR_016280</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Rtsne</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/Rtsne/index.html">https://cran.r-project.org/web/packages/Rtsne/index.html</ext-link></td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_016342">SCR_016342</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">PICRUSt</td><td valign="top">PMID 23975157</td><td valign="top">RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_016856">SCR_016856</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">HUMAnN</td><td valign="top">PMID 22719234</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_014620">SCR_014620</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Prism 7.0b</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://www.graphpad.com/scientific-software/prism/">https://www.graphpad.com/scientific-software/prism/</ext-link></td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_002798">SCR_002798</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">limma</td><td valign="top">PMID 25605792</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_010943">SCR_010943</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">QIIME</td><td valign="top">PMID: <break/>20383131</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_008249">SCR_008249</ext-link></td><td valign="top"/></tr><tr><td valign="top">Antibody</td><td valign="top">Rat anti mouse CD16/32 (clone 93)</td><td valign="top">Biolegend</td><td valign="top">Cat. #: 101310, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2103871">AB_2103871</ext-link></td><td valign="top">Flow cytometry (FC), FC receptor block 1:100</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rat anti mouse CD45 (clone 30-F11)</td><td valign="top">Biolegend</td><td valign="top">Cat. #: 103114, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_312979">AB_312979</ext-link></td><td valign="top">FC, PE/Cy7 1:100</td></tr><tr><td valign="top">Antibody</td><td valign="top">Armenian hamster anti mouse CD3e (clone 145–2 C11)</td><td valign="top">Biolegend</td><td valign="top">Cat. #: 100334, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2028475">AB_2028475</ext-link></td><td valign="top">FC, Pacific Blue 1:100</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rat anti mouse CD4 (clone GK1.5)</td><td valign="top">Biolegend</td><td valign="top">Cat. #: 100414, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_312981">AB_312981</ext-link></td><td valign="top">FC, APC/Cy7 1:100</td></tr><tr><td valign="top">Antibody</td><td valign="top">Mouse anti mouse GATA-3 (clone L50-823)</td><td valign="top">BD Biosciences</td><td valign="top">Cat. #: 560077, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_1645303">AB_1645303</ext-link></td><td valign="top">FC, Alexa Fluor 488 1:33</td></tr><tr><td valign="top">Antibody</td><td valign="top">Mouse anti mouse Foxp3 (clone 150D)</td><td valign="top">Biolegend</td><td valign="top">Cat. #: 320007, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_492981">AB_492981</ext-link></td><td valign="top">FC, PE 1:40</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rat anti mouse RORgt (clone B2D)</td><td valign="top">Invitrogen</td><td valign="top">Cat. #: 17-6981-82, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2573254">AB_2573254</ext-link></td><td valign="top">FC, APC 1:40</td></tr><tr><td valign="top">Antibody</td><td valign="top">Mouse anti mouse T-bet (clone 4B10)</td><td valign="top">Biolegend</td><td valign="top">Cat. #: 644806, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_1595488">AB_1595488</ext-link></td><td valign="top">FC, PerCP/Cy5 1:33</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rat anti mouse CD45 (clone 30-F11)</td><td valign="top">Biolegend</td><td valign="top">Cat. #: 103126, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_493535">AB_493535</ext-link></td><td valign="top">FC, Pacific Blue 1:100</td></tr><tr><td valign="top">Antibody</td><td valign="top">Armenian hamster anti mouse CD11c (clone N418)</td><td valign="top">Biolegend</td><td valign="top">Cat. #: 117306, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_313775">AB_313775</ext-link></td><td valign="top">FC, FITC 1:200</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rat anti mouse CD11b (clone M1/70)</td><td valign="top">Biolegend</td><td valign="top">Cat. #: 101228, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_893232">AB_893232</ext-link></td><td valign="top">FC, PerCP/Cy5 1:200</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rat anti mouse I-A/I-E (MHCII) (clone M5/114.15.2)</td><td valign="top">Biolegend</td><td valign="top">Cat. #: 107630, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2069376">AB_2069376</ext-link></td><td valign="top">FC, PE/Cy7 1:200</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rat anti mouse Ly-6G/Ly-6C (GR-1) (clone RB6-8C5)</td><td valign="top">Biolegend</td><td valign="top">Cat. #: 108412, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_313377">AB_313377</ext-link></td><td valign="top">FC, APC 1:200</td></tr><tr><td valign="top">Antibody</td><td valign="top">Armenian hamster anti mouse CD103 (clone 2E7)</td><td valign="top">Invitrogen</td><td valign="top">Cat. #: 12-1031-82, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_465799">AB_465799</ext-link></td><td valign="top">FC, PE 1:100</td></tr><tr><td valign="top">CommercialAssay or Kit</td><td valign="top">Live/Dead Fixable Yellow Dead Cell Stain</td><td valign="top">Thermo Fisher Scientific</td><td valign="top">Cat. #: L34959</td><td valign="top">FC</td></tr><tr><td valign="top">Commercial Assay or Kit</td><td valign="top">Quant-iT PicoGreen dsDNA Assay Kit</td><td valign="top">Thermo Fisher Scientific</td><td valign="top">Cat. #: P11496</td><td valign="top">DNA quantification</td></tr><tr><td valign="top">Commercial Assay or Kit</td><td valign="top">Nextera XT DNA Library Preparation Kit</td><td valign="top">Illumina</td><td valign="top">Cat. #: FC-131–1096</td><td valign="top">Sequencing libraries</td></tr><tr><td valign="top">Commercial Assay or Kit</td><td valign="top">Agilent DNA 1000 Kit</td><td valign="top">Agilent Technologies</td><td valign="top">Cat. #: 5067–1504</td><td valign="top">Insert sizes</td></tr><tr><td valign="top">Other</td><td valign="top">RNAlater</td><td valign="top">Sigma</td><td valign="top">Cat. #: R0901-500ML</td><td valign="top">Solution for stool sample collection</td></tr><tr><td valign="top">Commercial Assay or Kit</td><td valign="top">QIAamp 96 PowerFecal QIAcube HT Kit (5)</td><td valign="top">QIAGEN</td><td valign="top">Cat. #: 51531</td><td valign="top">Stool DNA extraction</td></tr><tr><td valign="top">Commercial Assay or Kit</td><td valign="top">Allprep DNA/RNA 96 Kit</td><td valign="top">QIAGEN</td><td valign="top">Cat. #: 80311</td><td valign="top">Stool DNA extraction</td></tr><tr><td valign="top">Other</td><td valign="top">IRS solution</td><td valign="top">QIAGEN</td><td valign="top">Cat. #: 26000-50-2</td><td valign="top">Solution for stool DNA extraction</td></tr><tr><td valign="top">Commercial <break/>Assay or Kit</td><td valign="top">PowerBead Plates, Glass</td><td valign="top">QIAGEN</td><td valign="top">Cat. #:27500–4-EP-BP</td><td valign="top">Stool DNA extraction</td></tr><tr><td valign="top">Other</td><td valign="top">Brucella agar sheeps blood/hemin/vitamin K plates</td><td valign="top">Hardy Diagnostics</td><td valign="top">Cat. #: A30</td><td valign="top">Bacterial culture plates</td></tr><tr><td valign="top">Commercial Assay or Kit</td><td valign="top">Rneasy Mini Kit</td><td valign="top">QIAGEN</td><td valign="top">Cat. #: 74106</td><td valign="top">RNA isolation</td></tr><tr><td valign="top">Commercial Assay or Kit</td><td valign="top">iScript cDNA synthesis kit</td><td valign="top">Bio-Rad</td><td valign="top">Cat. #:1708891</td><td valign="top">cDNA synthesis</td></tr></tbody></table></table-wrap><sec id="s4-1"><title>Mice</title><p>All mouse strains employed are on the C57BL/6J background and were sacrificed between 8–13 weeks of age. Generation of the ATG16L1 T300A knock-in mice has been previously described by <xref ref-type="bibr" rid="bib21">Haberman et al. (2014)</xref>. Conventionally-housed mice were kept at the Massachusetts General Hospital, and all procedures were performed in accordance with the Institutional Animal Care and Use Committee at Massachusetts General Hospital. ATG16L1 T300A knock-in mice were aseptically rederived as gnotobiotic animals and maintained in semi-rigid gnotobiotic isolators under a strict 12 hr light cycle in the Harvard T. H. Chan Gnotobiotic Center for Mechanistic Microbiome Studies. All gnotobiotic experiments were performed at the Harvard T. H. Chan Gnotobiotic Center for Mechanistic Microbiome Studies and were approved and carried out in accordance with Harvard Medical School's Standing Committee on Animals and the National Institutes of Health guidelines for animal use and care. Mice gavaged with different stool samples from human donors were maintained in separate isolator cages. For all mouse experiments a minimum of two experiments were conducted throughout.</p></sec><sec id="s4-2"><title>Dextran Sulfate Sodium treatment</title><p>Conventionally-housed mice were fed 2.5% (w/v) dextran sulfate sodium (DSS, MP Biomedicals; MW = 36,000–50,000) dissolved in sterile distilled drinking water ad libitum for 7 days, followed by 7 days of regular drinking water. Body weights were monitored daily. Stool samples were collected into RNAlater after the last day of regular drinking water and stored at −80°C until DNA was extracted for 16S rRNA gene amplicon sequencing.</p></sec><sec id="s4-3"><title>Mouse stool sample collection and DNA extraction</title><p>Stool samples for 16S rRNA amplicon surveys were collected into RNAlater and stored at −80°C prior to DNA extraction. The samples were then stored at −80°C until shipping to the Broad Institute for DNA extraction. For DNA extraction, a combination of the QIAamp 96 PowerFecal Qiacube HT Kit (Qiagen Cat No./ID: 51531), the Allprep DNA/RNA 96 Kit (Qiagen Cat No./ID: 80311), and IRS solution (Qiagen Cat No./ID: 26000-50-2) were used with a custom protocol. One mouse stool pellet per sample was transferred into individual wells of the PowerBead plate, with 0.1 mm glass beads (Cat No./ID: 27500–4-EP-BP) on dry ice. 650 μl of 56°C heated PW1 buffer with 1:100 vol addition of 1M DTT was added directly to each sample well before lysis by bead beating on a TissueLyzer II at 20 Hz for a total of 10 min. Samples pelleted by centrifugation for 6 min at 4500 x g. Supernatants transferred to a new S block (supplied in PowerFecal Kit) and combined with 150 μl of IRS solution and vortexed briefly before 1 min incubation. Sealed samples centrifuged again for 6 min, 4500 x g and up to 450 μl of supernatant were transferred to new S block, combined with 600 μl of Buffer C4 (PowerFecal Kit), mixed by pipetting 10x and incubated at room temperature for 1 min. Samples were transferred into AllPrep 96 DNA plate on top of clean S blocks and centrifuged for 3 min at 4500 x g. Step was repeated until all sample passed through. Allprep DNA plate was placed on top of a 2 mL waste block. 500 μl AW1 buffer was added to the DNA plate which was sealed and centrifuged for 4 min at 4500 x g. 500 μl AW2 buffer was added to the DNA plate, repeating centrifuge step. Allprep DNA plate was placed on top of elution plate. 100 μl of 70°C heated EB Buffer was added to each sample column and incubated for 5 min and centrifuged for 4 min at 4500 x g to elute. Purified DNA was stored at −20°C.</p></sec><sec id="s4-4"><title>Human stool sample collection for gnotobiotic mouse association studies</title><p>Human stool samples for association with gnotobiotic mice were acquired from patients from Massachusetts General Hospital according to institutional review board #2004P001067. Patients produced the sample at the hospital visit, and it was immediately stored at −80°C by the staff. Participants provided informed consent for the study and are part of the PRISM cohort study.</p></sec><sec id="s4-5"><title>Gnotobiotic mouse association with human stool</title><p>Frozen human stool samples (50 mg/mouse) were reconstituted in sterile PBS 0.05% Cysteine (250 mg/ml). 25 mg (100 ul) was orally instilled followed by 12.5 mg (50 ul) placed on the anus and 12.5 mg (50 ul) placed on the back fur of each mouse. Stool samples and gut tissues were collected at 4 weeks post human stool association.</p></sec><sec id="s4-6"><title>Gnotobiotic and ASF mouse association with bacteroides ovatus 8483</title><p><italic>Bacteroides ovatus</italic> 8483 (ATCC) was grown in liquid culture with <italic>Bacteroides</italic> basal medium as described in Pantosti et al (<xref ref-type="bibr" rid="bib53">Pantosti et al., 1991</xref>). GF or ASF mice were gavaged with ~10<sup>9</sup> CFU in 100 μl. Mice were sacrificed after 3 weeks. At sacrifice, stool samples were collected and weighed and CFU/g of stool was calculated after growth on Brucella agar plates with 5% sheep blood, hemin, and vitamin K1 (Hardy Diagnostics A30).</p></sec><sec id="s4-7"><title>Sequencing and analysis of the 16S Gene</title><p>16S rRNA gene libraries targeting the V4 region of the 16S rRNA gene were prepared by first normalizing template concentrations and determining optimal cycle number by way of qPCR. Two 25 μl reactions for each sample were amplified with 0.5 units of Phusion with 1X High Fidelity buffer, 200 μM of each dNTP, 0.3 μM of 515F (5’-AATGATACGGCGACCACCGAGATCTACACTATGGTAATTGTGTGCCAGCMGCCGCGGTAA-3’) and 806rcbc0 (5’CAAGCAGAAGACGGCATACGAGATTCCCTTGTCTCCAGTCAGTCAGCCGGACTACHVGGGTWTCTAAT-3’). 0.25 μl 100x SYBR were added to each reaction and samples were quantified using the formula 1.75^(deltaCt). To ensure minimal over-amplification, each sample was diluted to the lowest concentration sample, amplifying with this sample optimal cycle number for the library construction PCR. Four 25 μl reactions were prepared per sample with master mix conditions listed above, without SYBR. Each sample was given a unique reverse barcode primer from the Golay primer set (<xref ref-type="bibr" rid="bib4">Bloom et al., 2011</xref> and <xref ref-type="bibr" rid="bib35">Koropatkin et al., 2012</xref>). Replicates were then pooled and cleaned via Agencourt AMPure XP-PCR purification system. Purified libraries were diluted 1:100 and quantified again via qPCR (Two 25 μl reactions, 2x iQ SYBR SUPERMix (Bio-Rad, REF: 1708880 with Read 1 (5’-TATGGTAATT GT GTGYCAGCMGCCGCGGTAA-3’), Read 2 (5’-AGTCAGTCAG CC GGACTACNVGGGTWTCTAAT-3’). Undiluted samples were normalized by way of pooling using the formula mentioned above. Pools were quantified by Qubit (Life Technologies, Inc.) and normalized into a final pool by Qubit concentration and number of samples. Final pools were sequenced on an Illumina MiSeq 300 using custom index 5’-ATTAGAWACCCBDGTAGTCC GG CTGACTGACT-3’ and custom Read one and Read two mentioned above. 16S data were processed using QIIME (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_008249">SCR_008249</ext-link>), and taxonomy was assigned using the Greengenes predefined taxonomy map of reference sequence OTUs to taxonomy (<xref ref-type="bibr" rid="bib45">McDonald et al., 2012</xref>). The resulting OTU tables were checked for mislabeling<sup>71</sup>and contamination (<xref ref-type="bibr" rid="bib32">Knights et al., 2011b</xref>). A median sequence depth of 24,583 per sample was obtained, and samples with fewer than 5000 filtered sequences were excluded from analysis.</p></sec><sec id="s4-8"><title>Library construction</title><p>16S rRNA gene libraries were constructed as previously described (<xref ref-type="bibr" rid="bib36">Kostic et al., 2015</xref>)</p></sec><sec id="s4-9"><title>Metagenomics</title><p>DNA samples were quantified by Quant-iT PicoGreen dsDNA Assay (Life Technologies) and normalized to a concentration of 50 pg/μl. Illumina sequencing libraries were prepared from 100 to 250 pg of DNA using the Nextera XT DNA Library Preparation kit (Illumina) according to the manufacturer’s recommended protocol, with reaction volumes scaled accordingly. Prior to sequencing, libraries were pooled by collecting equal volumes (200 nl) of each library from batches of 96 samples. Insert sizes and concentrations for each pooled library were determined using an Agilent Bioanalyzer DNA 1000 kit (Agilent Technologies). Libraries were sequenced on HiSeq 2 × 101 to yield ~10 million PE reads. Post-sequencing de-multiplexing and generation of BAM and Fastq files are generated using the Picard suite (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_006525">SCR_006525</ext-link>) (<ext-link ext-link-type="uri" xlink:href="https://broadinstitute.github.io/picard/command-line-overview.html">https://broadinstitute.github.io/picard/command-line-overview.html</ext-link>). Metagenomic data were analyzed using MetaPhlAn (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_004915">SCR_004915</ext-link>) (v.2.2) (<xref ref-type="bibr" rid="bib71">Truong et al., 2015</xref>) for taxonomic profiling and HUMAnN2 (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_016280">SCR_016280</ext-link> (<ext-link ext-link-type="uri" xlink:href="http://huttenhower.sph.">http://huttenhower.sph.</ext-link> harvard.edu/humann2) for functional profiling. All sequencing data generated for these studies has been deposited at SRA #SUB4222585</p></sec><sec id="s4-10"><title>Principal coordinate and bacterial heatmap plots</title><p>Principal coordinate plots were generated using t-Distributed Stochastic Neighbor Embedding (t-SNE) as implemented in the R package Rtsne (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_016342">SCR_016342</ext-link>). Bray-Curtis dissimilarity, where xsi denotes the abundance of strain s in sample i, was used as the distance measure. We followed the guidelines given by the authors (FAQ at <ext-link ext-link-type="uri" xlink:href="http://lvdmaaten.github.io/tsne/">http://lvdmaaten.github.io/tsne/</ext-link>) and selected the free parameter, perplexity, by generating mappings with perplexity values between 5 and 50 in increments of 5. Mappings with lowest error and best visual properties were obtained using perplexity = 50. We set the absent proportion data to zeros and remapped the proportions (0, 1) to the interval (1e-7, 1 - 1e-7). We transformed the proportions using logit transformation, after which the data fit a normal distribution.</p></sec><sec id="s4-11"><title>PICRUSt analysis</title><p>Microbial functional modules were inferred from the 16S rRNA gene amplicon sequencing using PICRUSt (<xref ref-type="bibr" rid="bib37">Langille et al., 2013</xref>) (Phylogenetic Investigation of Communities by Reconstruction of Unobserved States) and functional modules were reconstructed using HUMAnN (<xref ref-type="bibr" rid="bib1">Abubucker et al., 2012</xref>) (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_014620">SCR_014620</ext-link>).</p></sec><sec id="s4-12"><title>Lamina Propria immune cell isolation</title><p>Four weeks post association with human stool, the colon and distal 10 centimeters of the small intestine (SI) were removed, opened longitudinally, and rinsed in PBS (Dulbecco’s – calcium and magnesium free) to remove fecal contents. The epithelial layer was removed using two rounds of 5 mM EDTA (10 ml/colon 25 ml/SI) rotating at 37C (round 1 includes 1 mM DTT). After removing the epithelial layer, the lamina propria was washed in PBS and chopped into ~1 mM pieces. The tissue was digested in RPMI with glutamine (Sigma) with the following: 10% FBS, 1% penicillin/streptomycin (Corning), 0.5 mg/ml Dispase (STEM cell tech), 1 mg/ml collagenase D (Roche), 50 µg/ml DNAse (Roche) in two rounds of 30 min rotating at 37C. Isolated single cells were filtered over 40 µM filter and resuspended in 5 mM EDTA followed by a wash with FACS buffer (2% FBS 1 mM EDTA). Cells were counted on the hemocytometer followed by flow cytometry analysis.</p></sec><sec id="s4-13"><title>Flow Cytometry</title><p>1 × 10<sup>6</sup> isolated colon lamina propria or small intestine lamina propria cells were stained with LIVE/DEAD<sup>TM</sup> fixable yellow dead cell stain kit (Thermo Fisher Scientific, L34959) for 15 min at room temperature. Cells were washed with FACS buffer and then stained with FC block (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2103871">AB_2103871</ext-link>, Biolegend, 101310) for 10 min on ice followed by mouse extracellular fluorochrome-conjugated antibodies against mouse: CD45 (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_312979">AB_312979</ext-link> and RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_493535">AB_493535</ext-link>), CD3 (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2028475">AB_2028475</ext-link>), CD4 (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_312981">AB_312981</ext-link>), CD11c (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_313775">AB_313775</ext-link>), CD11b (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_893232">AB_893232</ext-link>), MHCII (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2069376">AB_2069376</ext-link>), GR-1 (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_313377">AB_313377</ext-link>), and CD103 (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_465799">AB_465799</ext-link>). Cells were permeabilized and fixed using the Foxp3 Fix/Perm kit (Biolegend, 421403) and stained at room temperature for 45 min with the following intracellular antibodies against mouse: RORγt (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2573254">AB_2573254</ext-link>), T-bet (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_1595488">AB_1595488</ext-link>), Foxp3 (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_492981">AB_492981</ext-link>), or GATA-3 (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_1645303">AB_1645303</ext-link>). Flow cytometry was conducted using a BD LSR II.</p></sec><sec id="s4-14"><title>Colitis score</title><p>Gnotobiotically-housed mice associated with stool from human donors were sacrificed and colons were removed, opened longitudinally, placed in cassettes and fixed in 4% paraformaldehyde (Sigma-Aldrich) and embedded in paraffin. Sections (5 μM) were H and E-stained and evaluated in a blinded fashion for epithelial hyperplasia (0–3), epithelial injury (0–3), polymorphonuclear infiltration (0–3) and mononuclear infiltration (0–3).</p></sec><sec id="s4-15"><title>Statistical analysis</title><p>Statistical analysis for flow cytometry data was performed in Prism 7.0b (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_002798">SCR_002798</ext-link>). Data are plotted as mean ± SEM and either Mann-Whitney <italic>U</italic> test or two-way ANOVA as described in figure legend. p &lt; 0.05 was considered significant. ns = not significant. To discover association of bacterial abundance and the mouse genotype, we use limma (RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_010943">SCR_010943</ext-link>), an R package for linear modeling that powers differential expression analyses (<xref ref-type="bibr" rid="bib60">Ritchie et al., 2015</xref>). We adjusted for age, cage, and sex in the analysis. Corrected P-values were generated using Benjamani-Hochberg false discovery rate.</p></sec><sec id="s4-16"><title>qPCR</title><p>Expression of <italic>Il23p19</italic> was analyzed from total cells isolated from the colon and ileum lamina propria. Epithelial cells were removed as described in the lamina propria immune cell isolation methods described above. Lamina propria cells were resuspended in RLT buffer and frozen at −80C until further analysis. RNA was extracted using the RNeasy Mini kit (QIAGEN) and cDNA was generated using iScript cDNA synthesis Kit (Bio-Rad, 1708891). Quantitative PCR was conducted using the following primers for <italic>Il23p19</italic>: forward primer: AGCGGGACATATGAATCTACTAAGAGA, reverse primer: GTCCTAGTAGGGAGGTGTGAAGTTG.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>The authors thank the members of the Garrett lab for their thoughtful discussion, and Tiffany Poon of the Broad Institute and Elizabeth Andrews of MGH for coordinating the samples and patient cohorts. We would also like to thank the Broad Institute Microbial ‘omics core, Genomics Platform and Broad Technology Labs. We would like to thank Elizabeth A Creasey for animal husbandry and sample collection. We would also like to thank the Harvard T H Chan Gnotobiotic Center for Mechanistic Microbiome Studies. These studies were supported by RO1 CA154426 (WSG), DK097485 (RJX), DK092405 and R24 DK110499 (RX and WSG), DK105653 (SL) and a Smith Family Foundation Award for Excellence in Biomedical Research to ADK</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf2"><p>Senior editor, <italic>eLife</italic></p></fn><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing—original draft, Writing—review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Data curation, Investigation, Methodology, Writing—review and editing</p></fn><fn fn-type="con" id="con3"><p>Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing—review and editing</p></fn><fn fn-type="con" id="con4"><p>Data curation</p></fn><fn fn-type="con" id="con5"><p>Data curation, Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con6"><p>Data curation, Investigation</p></fn><fn fn-type="con" id="con7"><p>Data curation, Investigation</p></fn><fn fn-type="con" id="con8"><p>Data curation</p></fn><fn fn-type="con" id="con9"><p>Investigation</p></fn><fn fn-type="con" id="con10"><p>Formal analysis, Investigation</p></fn><fn fn-type="con" id="con11"><p>Data curation, Formal analysis, Investigation</p></fn><fn fn-type="con" id="con12"><p>Data curation, Formal analysis, Supervision, Investigation, Visualization, Methodology, Writing—review and editing</p></fn><fn fn-type="con" id="con13"><p>Investigation</p></fn><fn fn-type="con" id="con14"><p>Conceptualization, Data curation, Formal analysis, Funding acquisition, Validation, Investigation, Visualization, Methodology, Project administration, Writing—review and editing</p></fn><fn fn-type="con" id="con15"><p>Conceptualization, Resources, Data curation, Formal analysis, Supervision, Funding acquisition, Investigation, Visualization, Methodology, Writing—original draft, Project administration, Writing—review and editing</p></fn><fn fn-type="con" id="con16"><p>Conceptualization, Supervision, Funding acquisition, Investigation, Visualization, Methodology, Project administration, Writing—review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: Conventionally-housed mice were kept at the Massachusetts General Hospital, and all procedures were performed in accordance with the Institutional Animal Care and Use Committee at Massachusetts General Hospital. ATG16L1 T300A knock-in mice were aseptically rederived as gnotobiotic animals and maintained in semi-rigid gnotobiotic isolators under a strict 12-hour light cycle in the Harvard T. H. Chan Gnotobiotic Center for Mechanistic Microbiome Studies. All experiments were approved and carried out in accordance with Harvard Medical School's Standing Committee on Animals and the National Institutes of Health guidelines for animal use and care.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><object-id pub-id-type="doi">10.7554/eLife.39982.024</object-id><label>Supplementary file 1.</label><caption><title>Mouse caging and metadata for <xref ref-type="fig" rid="fig1">Figures 1</xref>–<xref ref-type="fig" rid="fig8">8</xref>.</title><p>Mouse genotype, age (wks), sex, cage, experiment description and figure are listed above. Mice housed together have the same cage number.</p></caption><media mime-subtype="octet-stream" mimetype="application" xlink:href="elife-39982-supp1-v1.pptx"/></supplementary-material><supplementary-material id="transrepform"><object-id pub-id-type="doi">10.7554/eLife.39982.025</object-id><label>Transparent reporting form</label><media mime-subtype="pdf" mimetype="application" xlink:href="elife-39982-transrepform-v1.pdf"/></supplementary-material><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>Human microbiome sequence data are available as noted in Jostins et al. 2012 and requests for access can be made via the NCBI Genotypes and Phenotypes database (additional details here <ext-link ext-link-type="uri" xlink:href="https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=login">https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=login</ext-link>). Mouse microbiome data have been submitted for deposit at NCBI sequence read archive SUB4222585.</p><p>The following dataset was generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Aleksander</surname><given-names>Kostic</given-names></name></person-group><year iso-8601-date="2018">2018</year><data-title>Illumina HiSeq 2000 sequencing of SAMD00080972</data-title><source>NCBI Sequence Read Archive</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/sra/?term=4222585">4222585</pub-id></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation id="dataset2" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Judy</surname><given-names>Cho</given-names></name></person-group><year iso-8601-date="2008">2008</year><data-title>NIDDK IBDGC Crohn's Disease Genome-Wide Association Study</data-title><source>NCBI Genotypes and Phenotypes database</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000130.v1.p1">phs000130.v1.p1</pub-id></element-citation></p><p><element-citation id="dataset3" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Judy</surname><given-names>Cho</given-names></name></person-group><year iso-8601-date="2012">2012</year><data-title>NIDDK IBD Genetics Consortium Ulcerative Colitis Genome-Wide Association Study</data-title><source>NCBI Genotypes and Phenotypes database</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000345.v1.p1">phs000345.v1.p1</pub-id></element-citation></p></sec></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abubucker</surname> <given-names>S</given-names></name><name><surname>Segata</surname> <given-names>N</given-names></name><name><surname>Goll</surname> <given-names>J</given-names></name><name><surname>Schubert</surname> <given-names>AM</given-names></name><name><surname>Izard</surname> <given-names>J</given-names></name><name><surname>Cantarel</surname> <given-names>BL</given-names></name><name><surname>Rodriguez-Mueller</surname> <given-names>B</given-names></name><name><surname>Zucker</surname> <given-names>J</given-names></name><name><surname>Thiagarajan</surname> <given-names>M</given-names></name><name><surname>Henrissat</surname> <given-names>B</given-names></name><name><surname>White</surname> <given-names>O</given-names></name><name><surname>Kelley</surname> <given-names>ST</given-names></name><name><surname>Methé</surname> <given-names>B</given-names></name><name><surname>Schloss</surname> <given-names>PD</given-names></name><name><surname>Gevers</surname> <given-names>D</given-names></name><name><surname>Mitreva</surname> <given-names>M</given-names></name><name><surname>Huttenhower</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Metabolic reconstruction for metagenomic data and its application to the human microbiome</article-title><source>PLOS Computational Biology</source><volume>8</volume><elocation-id>e1002358</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1002358</pub-id><pub-id pub-id-type="pmid">22719234</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andoh</surname> <given-names>A</given-names></name><name><surname>Zhang</surname> <given-names>Z</given-names></name><name><surname>Inatomi</surname> <given-names>O</given-names></name><name><surname>Fujino</surname> <given-names>S</given-names></name><name><surname>Deguchi</surname> <given-names>Y</given-names></name><name><surname>Araki</surname> <given-names>Y</given-names></name><name><surname>Tsujikawa</surname> <given-names>T</given-names></name><name><surname>Kitoh</surname> <given-names>K</given-names></name><name><surname>Kim-Mitsuyama</surname> <given-names>S</given-names></name><name><surname>Takayanagi</surname> <given-names>A</given-names></name><name><surname>Shimizu</surname> <given-names>N</given-names></name><name><surname>Fujiyama</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts</article-title><source>Gastroenterology</source><volume>129</volume><fpage>969</fpage><lpage>984</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2005.06.071</pub-id><pub-id pub-id-type="pmid">16143135</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bel</surname> <given-names>S</given-names></name><name><surname>Pendse</surname> <given-names>M</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Ruhn</surname> <given-names>KA</given-names></name><name><surname>Hassell</surname> <given-names>B</given-names></name><name><surname>Leal</surname> <given-names>T</given-names></name><name><surname>Winter</surname> <given-names>SE</given-names></name><name><surname>Xavier</surname> <given-names>RJ</given-names></name><name><surname>Hooper</surname> <given-names>LV</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Paneth cells secrete lysozyme via secretory autophagy during bacterial infection of the intestine</article-title><source>Science</source><volume>357</volume><fpage>1047</fpage><lpage>1052</lpage><pub-id pub-id-type="doi">10.1126/science.aal4677</pub-id><pub-id pub-id-type="pmid">28751470</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bloom</surname> <given-names>SM</given-names></name><name><surname>Bijanki</surname> <given-names>VN</given-names></name><name><surname>Nava</surname> <given-names>GM</given-names></name><name><surname>Sun</surname> <given-names>L</given-names></name><name><surname>Malvin</surname> <given-names>NP</given-names></name><name><surname>Donermeyer</surname> <given-names>DL</given-names></name><name><surname>Dunne</surname> <given-names>WM</given-names></name><name><surname>Allen</surname> <given-names>PM</given-names></name><name><surname>Stappenbeck</surname> <given-names>TS</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Commensal Bacteroides species induce colitis in host-genotype-specific fashion in a mouse model of inflammatory bowel disease</article-title><source>Cell Host &amp; Microbe</source><volume>9</volume><fpage>390</fpage><lpage>403</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2011.04.009</pub-id><pub-id pub-id-type="pmid">21575910</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cadwell</surname> <given-names>K</given-names></name><name><surname>Liu</surname> <given-names>JY</given-names></name><name><surname>Brown</surname> <given-names>SL</given-names></name><name><surname>Miyoshi</surname> <given-names>H</given-names></name><name><surname>Loh</surname> <given-names>J</given-names></name><name><surname>Lennerz</surname> <given-names>JK</given-names></name><name><surname>Kishi</surname> <given-names>C</given-names></name><name><surname>Kc</surname> <given-names>W</given-names></name><name><surname>Carrero</surname> <given-names>JA</given-names></name><name><surname>Hunt</surname> <given-names>S</given-names></name><name><surname>Stone</surname> <given-names>CD</given-names></name><name><surname>Brunt</surname> <given-names>EM</given-names></name><name><surname>Xavier</surname> <given-names>RJ</given-names></name><name><surname>Sleckman</surname> <given-names>BP</given-names></name><name><surname>Li</surname> <given-names>E</given-names></name><name><surname>Mizushima</surname> <given-names>N</given-names></name><name><surname>Stappenbeck</surname> <given-names>TS</given-names></name><name><surname>Virgin</surname> <given-names>HW</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells</article-title><source>Nature</source><volume>456</volume><fpage>259</fpage><lpage>263</lpage><pub-id pub-id-type="doi">10.1038/nature07416</pub-id><pub-id pub-id-type="pmid">18849966</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cadwell</surname> <given-names>K</given-names></name><name><surname>Patel</surname> <given-names>KK</given-names></name><name><surname>Komatsu</surname> <given-names>M</given-names></name><name><surname>Virgin</surname> <given-names>HW</given-names></name><name><surname>Stappenbeck</surname> <given-names>TS</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>A common role for Atg16L1, Atg5 and Atg7 in small intestinal Paneth cells and Crohn disease</article-title><source>Autophagy</source><volume>5</volume><fpage>250</fpage><lpage>252</lpage><pub-id pub-id-type="doi">10.4161/auto.5.2.7560</pub-id><pub-id pub-id-type="pmid">19139628</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname> <given-names>H</given-names></name><name><surname>Khosravi</surname> <given-names>A</given-names></name><name><surname>Kusumawardhani</surname> <given-names>IP</given-names></name><name><surname>Kwon</surname> <given-names>AH</given-names></name><name><surname>Vasconcelos</surname> <given-names>AC</given-names></name><name><surname>Cunha</surname> <given-names>LD</given-names></name><name><surname>Mayer</surname> <given-names>AE</given-names></name><name><surname>Shen</surname> <given-names>Y</given-names></name><name><surname>Wu</surname> <given-names>WL</given-names></name><name><surname>Kambal</surname> <given-names>A</given-names></name><name><surname>Targan</surname> <given-names>SR</given-names></name><name><surname>Xavier</surname> <given-names>RJ</given-names></name><name><surname>Ernst</surname> <given-names>PB</given-names></name><name><surname>Green</surname> <given-names>DR</given-names></name><name><surname>McGovern</surname> <given-names>DP</given-names></name><name><surname>Virgin</surname> <given-names>HW</given-names></name><name><surname>Mazmanian</surname> <given-names>SK</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease</article-title><source>Science</source><volume>352</volume><fpage>1116</fpage><lpage>1120</lpage><pub-id pub-id-type="doi">10.1126/science.aad9948</pub-id><pub-id pub-id-type="pmid">27230380</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conway</surname> <given-names>KL</given-names></name><name><surname>Kuballa</surname> <given-names>P</given-names></name><name><surname>Song</surname> <given-names>JH</given-names></name><name><surname>Patel</surname> <given-names>KK</given-names></name><name><surname>Castoreno</surname> <given-names>AB</given-names></name><name><surname>Yilmaz</surname> <given-names>OH</given-names></name><name><surname>Jijon</surname> <given-names>HB</given-names></name><name><surname>Zhang</surname> <given-names>M</given-names></name><name><surname>Aldrich</surname> <given-names>LN</given-names></name><name><surname>Villablanca</surname> <given-names>EJ</given-names></name><name><surname>Peloquin</surname> <given-names>JM</given-names></name><name><surname>Goel</surname> <given-names>G</given-names></name><name><surname>Lee</surname> <given-names>IA</given-names></name><name><surname>Mizoguchi</surname> <given-names>E</given-names></name><name><surname>Shi</surname> <given-names>HN</given-names></name><name><surname>Bhan</surname> <given-names>AK</given-names></name><name><surname>Shaw</surname> <given-names>SY</given-names></name><name><surname>Schreiber</surname> <given-names>SL</given-names></name><name><surname>Virgin</surname> <given-names>HW</given-names></name><name><surname>Shamji</surname> <given-names>AF</given-names></name><name><surname>Stappenbeck</surname> <given-names>TS</given-names></name><name><surname>Reinecker</surname> <given-names>HC</given-names></name><name><surname>Xavier</surname> <given-names>RJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Atg16l1 is required for autophagy in intestinal epithelial cells and protection of mice from Salmonella infection</article-title><source>Gastroenterology</source><volume>145</volume><fpage>1347</fpage><lpage>1357</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2013.08.035</pub-id><pub-id pub-id-type="pmid">23973919</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooney</surname> <given-names>R</given-names></name><name><surname>Baker</surname> <given-names>J</given-names></name><name><surname>Brain</surname> <given-names>O</given-names></name><name><surname>Danis</surname> <given-names>B</given-names></name><name><surname>Pichulik</surname> <given-names>T</given-names></name><name><surname>Allan</surname> <given-names>P</given-names></name><name><surname>Ferguson</surname> <given-names>DJ</given-names></name><name><surname>Campbell</surname> <given-names>BJ</given-names></name><name><surname>Jewell</surname> <given-names>D</given-names></name><name><surname>Simmons</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation</article-title><source>Nature Medicine</source><volume>16</volume><fpage>90</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1038/nm.2069</pub-id><pub-id pub-id-type="pmid">19966812</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daferera</surname> <given-names>N</given-names></name><name><surname>Kumawat</surname> <given-names>AK</given-names></name><name><surname>Hultgren-Hörnquist</surname> <given-names>E</given-names></name><name><surname>Ignatova</surname> <given-names>S</given-names></name><name><surname>Ström</surname> <given-names>M</given-names></name><name><surname>Münch</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Fecal stream diversion and mucosal cytokine levels in collagenous colitis: A case report</article-title><source>World Journal of Gastroenterology</source><volume>21</volume><fpage>6065</fpage><lpage>6071</lpage><pub-id pub-id-type="doi">10.3748/wjg.v21.i19.6065</pub-id><pub-id pub-id-type="pmid">26019474</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname> <given-names>JM</given-names></name><name><surname>Abreu</surname> <given-names>MT</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The innate immune system and inflammatory bowel disease</article-title><source>Scandinavian Journal of Gastroenterology</source><volume>50</volume><fpage>24</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.3109/00365521.2014.966321</pub-id><pub-id pub-id-type="pmid">25523553</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Lange</surname> <given-names>KM</given-names></name><name><surname>Moutsianas</surname> <given-names>L</given-names></name><name><surname>Lee</surname> <given-names>JC</given-names></name><name><surname>Lamb</surname> <given-names>CA</given-names></name><name><surname>Luo</surname> <given-names>Y</given-names></name><name><surname>Kennedy</surname> <given-names>NA</given-names></name><name><surname>Jostins</surname> <given-names>L</given-names></name><name><surname>Rice</surname> <given-names>DL</given-names></name><name><surname>Gutierrez-Achury</surname> <given-names>J</given-names></name><name><surname>Ji</surname> <given-names>SG</given-names></name><name><surname>Heap</surname> <given-names>G</given-names></name><name><surname>Nimmo</surname> <given-names>ER</given-names></name><name><surname>Edwards</surname> <given-names>C</given-names></name><name><surname>Henderson</surname> <given-names>P</given-names></name><name><surname>Mowat</surname> <given-names>C</given-names></name><name><surname>Sanderson</surname> <given-names>J</given-names></name><name><surname>Satsangi</surname> <given-names>J</given-names></name><name><surname>Simmons</surname> <given-names>A</given-names></name><name><surname>Wilson</surname> <given-names>DC</given-names></name><name><surname>Tremelling</surname> <given-names>M</given-names></name><name><surname>Hart</surname> <given-names>A</given-names></name><name><surname>Mathew</surname> <given-names>CG</given-names></name><name><surname>Newman</surname> <given-names>WG</given-names></name><name><surname>Parkes</surname> <given-names>M</given-names></name><name><surname>Lees</surname> <given-names>CW</given-names></name><name><surname>Uhlig</surname> <given-names>H</given-names></name><name><surname>Hawkey</surname> <given-names>C</given-names></name><name><surname>Prescott</surname> <given-names>NJ</given-names></name><name><surname>Ahmad</surname> <given-names>T</given-names></name><name><surname>Mansfield</surname> <given-names>JC</given-names></name><name><surname>Anderson</surname> <given-names>CA</given-names></name><name><surname>Barrett</surname> <given-names>JC</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease</article-title><source>Nature Genetics</source><volume>49</volume><fpage>256</fpage><lpage>261</lpage><pub-id pub-id-type="doi">10.1038/ng.3760</pub-id><pub-id pub-id-type="pmid">28067908</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eckburg</surname> <given-names>PB</given-names></name><name><surname>Relman</surname> <given-names>DA</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The role of microbes in Crohn's disease</article-title><source>Clinical Infectious Diseases</source><volume>44</volume><fpage>256</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.1086/510385</pub-id><pub-id pub-id-type="pmid">17173227</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elson</surname> <given-names>CO</given-names></name><name><surname>Cong</surname> <given-names>Y</given-names></name><name><surname>McCracken</surname> <given-names>VJ</given-names></name><name><surname>Dimmitt</surname> <given-names>RA</given-names></name><name><surname>Lorenz</surname> <given-names>RG</given-names></name><name><surname>Weaver</surname> <given-names>CT</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota</article-title><source>Immunological Reviews</source><volume>206</volume><fpage>260</fpage><lpage>276</lpage><pub-id pub-id-type="doi">10.1111/j.0105-2896.2005.00291.x</pub-id><pub-id pub-id-type="pmid">16048554</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname> <given-names>T</given-names></name><name><surname>Wang</surname> <given-names>L</given-names></name><name><surname>Schoeb</surname> <given-names>TR</given-names></name><name><surname>Elson</surname> <given-names>CO</given-names></name><name><surname>Cong</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Microbiota innate stimulation is a prerequisite for T cell spontaneous proliferation and induction of experimental colitis</article-title><source>The Journal of Experimental Medicine</source><volume>207</volume><fpage>1321</fpage><lpage>1332</lpage><pub-id pub-id-type="doi">10.1084/jem.20092253</pub-id><pub-id pub-id-type="pmid">20498021</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frank</surname> <given-names>DN</given-names></name><name><surname>St Amand</surname> <given-names>AL</given-names></name><name><surname>Feldman</surname> <given-names>RA</given-names></name><name><surname>Boedeker</surname> <given-names>EC</given-names></name><name><surname>Harpaz</surname> <given-names>N</given-names></name><name><surname>Pace</surname> <given-names>NR</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases</article-title><source>PNAS</source><volume>104</volume><fpage>13780</fpage><lpage>13785</lpage><pub-id pub-id-type="doi">10.1073/pnas.0706625104</pub-id><pub-id pub-id-type="pmid">17699621</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujino</surname> <given-names>S</given-names></name><name><surname>Andoh</surname> <given-names>A</given-names></name><name><surname>Bamba</surname> <given-names>S</given-names></name><name><surname>Ogawa</surname> <given-names>A</given-names></name><name><surname>Hata</surname> <given-names>K</given-names></name><name><surname>Araki</surname> <given-names>Y</given-names></name><name><surname>Bamba</surname> <given-names>T</given-names></name><name><surname>Fujiyama</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Increased expression of interleukin 17 in inflammatory bowel disease</article-title><source>Gut</source><volume>52</volume><fpage>65</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1136/gut.52.1.65</pub-id><pub-id pub-id-type="pmid">12477762</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garrett</surname> <given-names>WS</given-names></name><name><surname>Gordon</surname> <given-names>JI</given-names></name><name><surname>Glimcher</surname> <given-names>LH</given-names></name></person-group><year iso-8601-date="2010">2010a</year><article-title>Homeostasis and inflammation in the intestine</article-title><source>Cell</source><volume>140</volume><fpage>859</fpage><lpage>870</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2010.01.023</pub-id><pub-id pub-id-type="pmid">20303876</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garrett</surname> <given-names>WS</given-names></name><name><surname>Gallini</surname> <given-names>CA</given-names></name><name><surname>Yatsunenko</surname> <given-names>T</given-names></name><name><surname>Michaud</surname> <given-names>M</given-names></name><name><surname>DuBois</surname> <given-names>A</given-names></name><name><surname>Delaney</surname> <given-names>ML</given-names></name><name><surname>Punit</surname> <given-names>S</given-names></name><name><surname>Karlsson</surname> <given-names>M</given-names></name><name><surname>Bry</surname> <given-names>L</given-names></name><name><surname>Glickman</surname> <given-names>JN</given-names></name><name><surname>Gordon</surname> <given-names>JI</given-names></name><name><surname>Onderdonk</surname> <given-names>AB</given-names></name><name><surname>Glimcher</surname> <given-names>LH</given-names></name></person-group><year iso-8601-date="2010">2010b</year><article-title>Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis</article-title><source>Cell Host &amp; Microbe</source><volume>8</volume><fpage>292</fpage><lpage>300</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2010.08.004</pub-id><pub-id pub-id-type="pmid">20833380</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gophna</surname> <given-names>U</given-names></name><name><surname>Sommerfeld</surname> <given-names>K</given-names></name><name><surname>Gophna</surname> <given-names>S</given-names></name><name><surname>Doolittle</surname> <given-names>WF</given-names></name><name><surname>Veldhuyzen van Zanten</surname> <given-names>SJ</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Differences between tissue-associated intestinal microfloras of patients with Crohn's disease and ulcerative colitis</article-title><source>Journal of Clinical Microbiology</source><volume>44</volume><fpage>4136</fpage><lpage>4141</lpage><pub-id pub-id-type="doi">10.1128/JCM.01004-06</pub-id><pub-id pub-id-type="pmid">16988016</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haberman</surname> <given-names>Y</given-names></name><name><surname>Tickle</surname> <given-names>TL</given-names></name><name><surname>Dexheimer</surname> <given-names>PJ</given-names></name><name><surname>Kim</surname> <given-names>MO</given-names></name><name><surname>Tang</surname> <given-names>D</given-names></name><name><surname>Karns</surname> <given-names>R</given-names></name><name><surname>Baldassano</surname> <given-names>RN</given-names></name><name><surname>Noe</surname> <given-names>JD</given-names></name><name><surname>Rosh</surname> <given-names>J</given-names></name><name><surname>Markowitz</surname> <given-names>J</given-names></name><name><surname>Heyman</surname> <given-names>MB</given-names></name><name><surname>Griffiths</surname> <given-names>AM</given-names></name><name><surname>Crandall</surname> <given-names>WV</given-names></name><name><surname>Mack</surname> <given-names>DR</given-names></name><name><surname>Baker</surname> <given-names>SS</given-names></name><name><surname>Huttenhower</surname> <given-names>C</given-names></name><name><surname>Keljo</surname> <given-names>DJ</given-names></name><name><surname>Hyams</surname> <given-names>JS</given-names></name><name><surname>Kugathasan</surname> <given-names>S</given-names></name><name><surname>Walters</surname> <given-names>TD</given-names></name><name><surname>Aronow</surname> <given-names>B</given-names></name><name><surname>Xavier</surname> <given-names>RJ</given-names></name><name><surname>Gevers</surname> <given-names>D</given-names></name><name><surname>Denson</surname> <given-names>LA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature</article-title><source>Journal of Clinical Investigation</source><volume>124</volume><fpage>3617</fpage><lpage>3633</lpage><pub-id pub-id-type="doi">10.1172/JCI75436</pub-id><pub-id pub-id-type="pmid">25003194</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname> <given-names>AB</given-names></name><name><surname>Yassour</surname> <given-names>M</given-names></name><name><surname>Sauk</surname> <given-names>J</given-names></name><name><surname>Garner</surname> <given-names>A</given-names></name><name><surname>Jiang</surname> <given-names>X</given-names></name><name><surname>Arthur</surname> <given-names>T</given-names></name><name><surname>Lagoudas</surname> <given-names>GK</given-names></name><name><surname>Vatanen</surname> <given-names>T</given-names></name><name><surname>Fornelos</surname> <given-names>N</given-names></name><name><surname>Wilson</surname> <given-names>R</given-names></name><name><surname>Bertha</surname> <given-names>M</given-names></name><name><surname>Cohen</surname> <given-names>M</given-names></name><name><surname>Garber</surname> <given-names>J</given-names></name><name><surname>Khalili</surname> <given-names>H</given-names></name><name><surname>Gevers</surname> <given-names>D</given-names></name><name><surname>Ananthakrishnan</surname> <given-names>AN</given-names></name><name><surname>Kugathasan</surname> <given-names>S</given-names></name><name><surname>Lander</surname> <given-names>ES</given-names></name><name><surname>Blainey</surname> <given-names>P</given-names></name><name><surname>Vlamakis</surname> <given-names>H</given-names></name><name><surname>Xavier</surname> <given-names>RJ</given-names></name><name><surname>Huttenhower</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2017">2017a</year><article-title>A novel Ruminococcus gnavus clade enriched in inflammatory bowel disease patients</article-title><source>Genome Medicine</source><volume>9</volume><fpage>103</fpage><pub-id pub-id-type="doi">10.1186/s13073-017-0490-5</pub-id><pub-id pub-id-type="pmid">29183332</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname> <given-names>AB</given-names></name><name><surname>Tolonen</surname> <given-names>AC</given-names></name><name><surname>Xavier</surname> <given-names>RJ</given-names></name></person-group><year iso-8601-date="2017">2017b</year><article-title>Human genetic variation and the gut microbiome in disease</article-title><source>Nature Reviews Genetics</source><volume>18</volume><fpage>690</fpage><lpage>699</lpage><pub-id pub-id-type="doi">10.1038/nrg.2017.63</pub-id><pub-id pub-id-type="pmid">28824167</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hampe</surname> <given-names>J</given-names></name><name><surname>Franke</surname> <given-names>A</given-names></name><name><surname>Rosenstiel</surname> <given-names>P</given-names></name><name><surname>Till</surname> <given-names>A</given-names></name><name><surname>Teuber</surname> <given-names>M</given-names></name><name><surname>Huse</surname> <given-names>K</given-names></name><name><surname>Albrecht</surname> <given-names>M</given-names></name><name><surname>Mayr</surname> <given-names>G</given-names></name><name><surname>De La Vega</surname> <given-names>FM</given-names></name><name><surname>Briggs</surname> <given-names>J</given-names></name><name><surname>Günther</surname> <given-names>S</given-names></name><name><surname>Prescott</surname> <given-names>NJ</given-names></name><name><surname>Onnie</surname> <given-names>CM</given-names></name><name><surname>Häsler</surname> <given-names>R</given-names></name><name><surname>Sipos</surname> <given-names>B</given-names></name><name><surname>Fölsch</surname> <given-names>UR</given-names></name><name><surname>Lengauer</surname> <given-names>T</given-names></name><name><surname>Platzer</surname> <given-names>M</given-names></name><name><surname>Mathew</surname> <given-names>CG</given-names></name><name><surname>Krawczak</surname> <given-names>M</given-names></name><name><surname>Schreiber</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1</article-title><source>Nature Genetics</source><volume>39</volume><fpage>207</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1038/ng1954</pub-id><pub-id pub-id-type="pmid">17200669</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hold</surname> <given-names>GL</given-names></name><name><surname>Smith</surname> <given-names>M</given-names></name><name><surname>Grange</surname> <given-names>C</given-names></name><name><surname>Watt</surname> <given-names>ER</given-names></name><name><surname>El-Omar</surname> <given-names>EM</given-names></name><name><surname>Mukhopadhya</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years?</article-title><source>World Journal of Gastroenterology</source><volume>20</volume><fpage>1192</fpage><lpage>1210</lpage><pub-id pub-id-type="doi">10.3748/wjg.v20.i5.1192</pub-id><pub-id pub-id-type="pmid">24574795</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Homer</surname> <given-names>CR</given-names></name><name><surname>Richmond</surname> <given-names>AL</given-names></name><name><surname>Rebert</surname> <given-names>NA</given-names></name><name><surname>Achkar</surname> <given-names>J-P</given-names></name><name><surname>McDonald</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>ATG16L1 and NOD2 interact in an autophagy-dependent antibacterial pathway implicated in Crohn's disease pathogenesis</article-title><source>Gastroenterology</source><volume>1392</volume><fpage>1630</fpage><lpage>1641</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2010.07.006</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imhann</surname> <given-names>F</given-names></name><name><surname>Vich Vila</surname> <given-names>A</given-names></name><name><surname>Bonder</surname> <given-names>MJ</given-names></name><name><surname>Fu</surname> <given-names>J</given-names></name><name><surname>Gevers</surname> <given-names>D</given-names></name><name><surname>Visschedijk</surname> <given-names>MC</given-names></name><name><surname>Spekhorst</surname> <given-names>LM</given-names></name><name><surname>Alberts</surname> <given-names>R</given-names></name><name><surname>Franke</surname> <given-names>L</given-names></name><name><surname>van Dullemen</surname> <given-names>HM</given-names></name><name><surname>Ter Steege</surname> <given-names>RWF</given-names></name><name><surname>Huttenhower</surname> <given-names>C</given-names></name><name><surname>Dijkstra</surname> <given-names>G</given-names></name><name><surname>Xavier</surname> <given-names>RJ</given-names></name><name><surname>Festen</surname> <given-names>EAM</given-names></name><name><surname>Wijmenga</surname> <given-names>C</given-names></name><name><surname>Zhernakova</surname> <given-names>A</given-names></name><name><surname>Weersma</surname> <given-names>RK</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease</article-title><source>Gut</source><volume>67</volume><fpage>108</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1136/gutjnl-2016-312135</pub-id><pub-id pub-id-type="pmid">27802154</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inoue</surname> <given-names>S</given-names></name><name><surname>Matsumoto</surname> <given-names>T</given-names></name><name><surname>Iida</surname> <given-names>M</given-names></name><name><surname>Mizuno</surname> <given-names>M</given-names></name><name><surname>Kuroki</surname> <given-names>F</given-names></name><name><surname>Hoshika</surname> <given-names>K</given-names></name><name><surname>Shimizu</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Characterization of cytokine expression in the rectal mucosa of ulcerative colitis: correlation with disease activity</article-title><source>The American Journal of Gastroenterology</source><volume>94</volume><fpage>2441</fpage><lpage>2446</lpage><pub-id pub-id-type="doi">10.1111/j.1572-0241.1999.01372.x</pub-id><pub-id pub-id-type="pmid">10484006</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jostins</surname> <given-names>L</given-names></name><name><surname>Ripke</surname> <given-names>S</given-names></name><name><surname>Weersma</surname> <given-names>RK</given-names></name><name><surname>Duerr</surname> <given-names>RH</given-names></name><name><surname>McGovern</surname> <given-names>DP</given-names></name><name><surname>Hui</surname> <given-names>KY</given-names></name><name><surname>Lee</surname> <given-names>JC</given-names></name><name><surname>Schumm</surname> <given-names>LP</given-names></name><name><surname>Sharma</surname> <given-names>Y</given-names></name><name><surname>Anderson</surname> <given-names>CA</given-names></name><name><surname>Essers</surname> <given-names>J</given-names></name><name><surname>Mitrovic</surname> <given-names>M</given-names></name><name><surname>Ning</surname> <given-names>K</given-names></name><name><surname>Cleynen</surname> <given-names>I</given-names></name><name><surname>Theatre</surname> <given-names>E</given-names></name><name><surname>Spain</surname> <given-names>SL</given-names></name><name><surname>Raychaudhuri</surname> <given-names>S</given-names></name><name><surname>Goyette</surname> <given-names>P</given-names></name><name><surname>Wei</surname> <given-names>Z</given-names></name><name><surname>Abraham</surname> <given-names>C</given-names></name><name><surname>Achkar</surname> <given-names>JP</given-names></name><name><surname>Ahmad</surname> <given-names>T</given-names></name><name><surname>Amininejad</surname> <given-names>L</given-names></name><name><surname>Ananthakrishnan</surname> <given-names>AN</given-names></name><name><surname>Andersen</surname> <given-names>V</given-names></name><name><surname>Andrews</surname> <given-names>JM</given-names></name><name><surname>Baidoo</surname> <given-names>L</given-names></name><name><surname>Balschun</surname> <given-names>T</given-names></name><name><surname>Bampton</surname> <given-names>PA</given-names></name><name><surname>Bitton</surname> <given-names>A</given-names></name><name><surname>Boucher</surname> <given-names>G</given-names></name><name><surname>Brand</surname> <given-names>S</given-names></name><name><surname>Büning</surname> <given-names>C</given-names></name><name><surname>Cohain</surname> <given-names>A</given-names></name><name><surname>Cichon</surname> <given-names>S</given-names></name><name><surname>D'Amato</surname> <given-names>M</given-names></name><name><surname>De Jong</surname> <given-names>D</given-names></name><name><surname>Devaney</surname> <given-names>KL</given-names></name><name><surname>Dubinsky</surname> <given-names>M</given-names></name><name><surname>Edwards</surname> <given-names>C</given-names></name><name><surname>Ellinghaus</surname> <given-names>D</given-names></name><name><surname>Ferguson</surname> <given-names>LR</given-names></name><name><surname>Franchimont</surname> <given-names>D</given-names></name><name><surname>Fransen</surname> <given-names>K</given-names></name><name><surname>Gearry</surname> <given-names>R</given-names></name><name><surname>Georges</surname> <given-names>M</given-names></name><name><surname>Gieger</surname> <given-names>C</given-names></name><name><surname>Glas</surname> <given-names>J</given-names></name><name><surname>Haritunians</surname> <given-names>T</given-names></name><name><surname>Hart</surname> <given-names>A</given-names></name><name><surname>Hawkey</surname> <given-names>C</given-names></name><name><surname>Hedl</surname> <given-names>M</given-names></name><name><surname>Hu</surname> <given-names>X</given-names></name><name><surname>Karlsen</surname> <given-names>TH</given-names></name><name><surname>Kupcinskas</surname> <given-names>L</given-names></name><name><surname>Kugathasan</surname> <given-names>S</given-names></name><name><surname>Latiano</surname> <given-names>A</given-names></name><name><surname>Laukens</surname> <given-names>D</given-names></name><name><surname>Lawrance</surname> <given-names>IC</given-names></name><name><surname>Lees</surname> <given-names>CW</given-names></name><name><surname>Louis</surname> <given-names>E</given-names></name><name><surname>Mahy</surname> <given-names>G</given-names></name><name><surname>Mansfield</surname> <given-names>J</given-names></name><name><surname>Morgan</surname> <given-names>AR</given-names></name><name><surname>Mowat</surname> <given-names>C</given-names></name><name><surname>Newman</surname> <given-names>W</given-names></name><name><surname>Palmieri</surname> <given-names>O</given-names></name><name><surname>Ponsioen</surname> <given-names>CY</given-names></name><name><surname>Potocnik</surname> <given-names>U</given-names></name><name><surname>Prescott</surname> <given-names>NJ</given-names></name><name><surname>Regueiro</surname> <given-names>M</given-names></name><name><surname>Rotter</surname> <given-names>JI</given-names></name><name><surname>Russell</surname> <given-names>RK</given-names></name><name><surname>Sanderson</surname> <given-names>JD</given-names></name><name><surname>Sans</surname> <given-names>M</given-names></name><name><surname>Satsangi</surname> <given-names>J</given-names></name><name><surname>Schreiber</surname> <given-names>S</given-names></name><name><surname>Simms</surname> <given-names>LA</given-names></name><name><surname>Sventoraityte</surname> <given-names>J</given-names></name><name><surname>Targan</surname> <given-names>SR</given-names></name><name><surname>Taylor</surname> <given-names>KD</given-names></name><name><surname>Tremelling</surname> <given-names>M</given-names></name><name><surname>Verspaget</surname> <given-names>HW</given-names></name><name><surname>De Vos</surname> <given-names>M</given-names></name><name><surname>Wijmenga</surname> <given-names>C</given-names></name><name><surname>Wilson</surname> <given-names>DC</given-names></name><name><surname>Winkelmann</surname> <given-names>J</given-names></name><name><surname>Xavier</surname> <given-names>RJ</given-names></name><name><surname>Zeissig</surname> <given-names>S</given-names></name><name><surname>Zhang</surname> <given-names>B</given-names></name><name><surname>Zhang</surname> <given-names>CK</given-names></name><name><surname>Zhao</surname> <given-names>H</given-names></name><name><surname>Silverberg</surname> <given-names>MS</given-names></name><name><surname>Annese</surname> <given-names>V</given-names></name><name><surname>Hakonarson</surname> <given-names>H</given-names></name><name><surname>Brant</surname> <given-names>SR</given-names></name><name><surname>Radford-Smith</surname> <given-names>G</given-names></name><name><surname>Mathew</surname> <given-names>CG</given-names></name><name><surname>Rioux</surname> <given-names>JD</given-names></name><name><surname>Schadt</surname> <given-names>EE</given-names></name><name><surname>Daly</surname> <given-names>MJ</given-names></name><name><surname>Franke</surname> <given-names>A</given-names></name><name><surname>Parkes</surname> <given-names>M</given-names></name><name><surname>Vermeire</surname> <given-names>S</given-names></name><name><surname>Barrett</surname> <given-names>JC</given-names></name><name><surname>Cho</surname> <given-names>JH</given-names></name><collab>International IBD Genetics Consortium (IIBDGC)</collab></person-group><year iso-8601-date="2012">2012</year><article-title>Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease</article-title><source>Nature</source><volume>491</volume><fpage>119</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.1038/nature11582</pub-id><pub-id pub-id-type="pmid">23128233</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khor</surname> <given-names>B</given-names></name><name><surname>Gardet</surname> <given-names>A</given-names></name><name><surname>Xavier</surname> <given-names>RJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Genetics and pathogenesis of inflammatory bowel disease</article-title><source>Nature</source><volume>474</volume><fpage>307</fpage><lpage>317</lpage><pub-id pub-id-type="doi">10.1038/nature10209</pub-id><pub-id pub-id-type="pmid">21677747</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knights</surname> <given-names>D</given-names></name><name><surname>Kuczynski</surname> <given-names>J</given-names></name><name><surname>Koren</surname> <given-names>O</given-names></name><name><surname>Ley</surname> <given-names>RE</given-names></name><name><surname>Field</surname> <given-names>D</given-names></name><name><surname>Knight</surname> <given-names>R</given-names></name><name><surname>DeSantis</surname> <given-names>TZ</given-names></name><name><surname>Kelley</surname> <given-names>ST</given-names></name></person-group><year iso-8601-date="2011">2011a</year><article-title>Supervised classification of microbiota mitigates mislabeling errors</article-title><source>The ISME Journal</source><volume>5</volume><fpage>570</fpage><lpage>573</lpage><pub-id pub-id-type="doi">10.1038/ismej.2010.148</pub-id><pub-id pub-id-type="pmid">20927137</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knights</surname> <given-names>D</given-names></name><name><surname>Kuczynski</surname> <given-names>J</given-names></name><name><surname>Charlson</surname> <given-names>ES</given-names></name><name><surname>Zaneveld</surname> <given-names>J</given-names></name><name><surname>Mozer</surname> <given-names>MC</given-names></name><name><surname>Collman</surname> <given-names>RG</given-names></name><name><surname>Bushman</surname> <given-names>FD</given-names></name><name><surname>Knight</surname> <given-names>R</given-names></name><name><surname>Kelley</surname> <given-names>ST</given-names></name></person-group><year iso-8601-date="2011">2011b</year><article-title>Bayesian community-wide culture-independent microbial source tracking</article-title><source>Nature Methods</source><volume>8</volume><fpage>761</fpage><lpage>763</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1650</pub-id><pub-id pub-id-type="pmid">21765408</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knights</surname> <given-names>D</given-names></name><name><surname>Silverberg</surname> <given-names>MS</given-names></name><name><surname>Weersma</surname> <given-names>RK</given-names></name><name><surname>Gevers</surname> <given-names>D</given-names></name><name><surname>Dijkstra</surname> <given-names>G</given-names></name><name><surname>Huang</surname> <given-names>H</given-names></name><name><surname>Tyler</surname> <given-names>AD</given-names></name><name><surname>van Sommeren</surname> <given-names>S</given-names></name><name><surname>Imhann</surname> <given-names>F</given-names></name><name><surname>Stempak</surname> <given-names>JM</given-names></name><name><surname>Huang</surname> <given-names>H</given-names></name><name><surname>Vangay</surname> <given-names>P</given-names></name><name><surname>Al-Ghalith</surname> <given-names>GA</given-names></name><name><surname>Russell</surname> <given-names>C</given-names></name><name><surname>Sauk</surname> <given-names>J</given-names></name><name><surname>Knight</surname> <given-names>J</given-names></name><name><surname>Daly</surname> <given-names>MJ</given-names></name><name><surname>Huttenhower</surname> <given-names>C</given-names></name><name><surname>Xavier</surname> <given-names>RJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Complex host genetics influence the microbiome in inflammatory bowel disease</article-title><source>Genome Medicine</source><volume>6</volume><fpage>107</fpage><pub-id pub-id-type="doi">10.1186/s13073-014-0107-1</pub-id><pub-id pub-id-type="pmid">25587358</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ko</surname> <given-names>SH</given-names></name><name><surname>Jeon</surname> <given-names>JI</given-names></name><name><surname>Myung</surname> <given-names>HS</given-names></name><name><surname>Kim</surname> <given-names>YJ</given-names></name><name><surname>Kim</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Bacteroides fragilis Enterotoxin Induces Formation of Autophagosomes in Endothelial Cells but Interferes with Fusion with Lysosomes for Complete Autophagic Flux through a Mitogen-Activated Protein Kinase-, AP-1-, and C/EBP Homologous Protein-Dependent Pathway</article-title><source>Infection and Immunity</source><volume>85</volume><fpage>e00420</fpage><lpage>e17</lpage><pub-id pub-id-type="doi">10.1128/IAI.00420-17</pub-id><pub-id pub-id-type="pmid">28694294</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koropatkin</surname> <given-names>NM</given-names></name><name><surname>Cameron</surname> <given-names>EA</given-names></name><name><surname>Martens</surname> <given-names>EC</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>How glycan metabolism shapes the human gut microbiota</article-title><source>Nature Reviews Microbiology</source><volume>10</volume><fpage>323</fpage><lpage>335</lpage><pub-id pub-id-type="doi">10.1038/nrmicro2746</pub-id><pub-id pub-id-type="pmid">22491358</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kostic</surname> <given-names>AD</given-names></name><name><surname>Gevers</surname> <given-names>D</given-names></name><name><surname>Siljander</surname> <given-names>H</given-names></name><name><surname>Vatanen</surname> <given-names>T</given-names></name><name><surname>Hyötyläinen</surname> <given-names>T</given-names></name><name><surname>Hämäläinen</surname> <given-names>AM</given-names></name><name><surname>Peet</surname> <given-names>A</given-names></name><name><surname>Tillmann</surname> <given-names>V</given-names></name><name><surname>Pöhö</surname> <given-names>P</given-names></name><name><surname>Mattila</surname> <given-names>I</given-names></name><name><surname>Lähdesmäki</surname> <given-names>H</given-names></name><name><surname>Franzosa</surname> <given-names>EA</given-names></name><name><surname>Vaarala</surname> <given-names>O</given-names></name><name><surname>de Goffau</surname> <given-names>M</given-names></name><name><surname>Harmsen</surname> <given-names>H</given-names></name><name><surname>Ilonen</surname> <given-names>J</given-names></name><name><surname>Virtanen</surname> <given-names>SM</given-names></name><name><surname>Clish</surname> <given-names>CB</given-names></name><name><surname>Orešič</surname> <given-names>M</given-names></name><name><surname>Huttenhower</surname> <given-names>C</given-names></name><name><surname>Knip</surname> <given-names>M</given-names></name><name><surname>Xavier</surname> <given-names>RJ</given-names></name><collab>DIABIMMUNE Study Group</collab></person-group><year iso-8601-date="2015">2015</year><article-title>The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes</article-title><source>Cell Host &amp; Microbe</source><volume>17</volume><fpage>260</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2015.01.001</pub-id><pub-id pub-id-type="pmid">25662751</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langille</surname> <given-names>MG</given-names></name><name><surname>Zaneveld</surname> <given-names>J</given-names></name><name><surname>Caporaso</surname> <given-names>JG</given-names></name><name><surname>McDonald</surname> <given-names>D</given-names></name><name><surname>Knights</surname> <given-names>D</given-names></name><name><surname>Reyes</surname> <given-names>JA</given-names></name><name><surname>Clemente</surname> <given-names>JC</given-names></name><name><surname>Burkepile</surname> <given-names>DE</given-names></name><name><surname>Vega Thurber</surname> <given-names>RL</given-names></name><name><surname>Knight</surname> <given-names>R</given-names></name><name><surname>Beiko</surname> <given-names>RG</given-names></name><name><surname>Huttenhower</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences</article-title><source>Nature Biotechnology</source><volume>31</volume><fpage>814</fpage><lpage>821</lpage><pub-id pub-id-type="doi">10.1038/nbt.2676</pub-id><pub-id pub-id-type="pmid">23975157</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langrish</surname> <given-names>CL</given-names></name><name><surname>Chen</surname> <given-names>Y</given-names></name><name><surname>Blumenschein</surname> <given-names>WM</given-names></name><name><surname>Mattson</surname> <given-names>J</given-names></name><name><surname>Basham</surname> <given-names>B</given-names></name><name><surname>Sedgwick</surname> <given-names>JD</given-names></name><name><surname>McClanahan</surname> <given-names>T</given-names></name><name><surname>Kastelein</surname> <given-names>RA</given-names></name><name><surname>Cua</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>IL-23 drives a pathogenic T cell population that induces autoimmune inflammation</article-title><source>The Journal of Experimental Medicine</source><volume>201</volume><fpage>233</fpage><lpage>240</lpage><pub-id pub-id-type="doi">10.1084/jem.20041257</pub-id><pub-id pub-id-type="pmid">15657292</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lassen</surname> <given-names>KG</given-names></name><name><surname>Kuballa</surname> <given-names>P</given-names></name><name><surname>Conway</surname> <given-names>KL</given-names></name><name><surname>Patel</surname> <given-names>KK</given-names></name><name><surname>Becker</surname> <given-names>CE</given-names></name><name><surname>Peloquin</surname> <given-names>JM</given-names></name><name><surname>Villablanca</surname> <given-names>EJ</given-names></name><name><surname>Norman</surname> <given-names>JM</given-names></name><name><surname>Liu</surname> <given-names>TC</given-names></name><name><surname>Heath</surname> <given-names>RJ</given-names></name><name><surname>Becker</surname> <given-names>ML</given-names></name><name><surname>Fagbami</surname> <given-names>L</given-names></name><name><surname>Horn</surname> <given-names>H</given-names></name><name><surname>Mercer</surname> <given-names>J</given-names></name><name><surname>Yilmaz</surname> <given-names>OH</given-names></name><name><surname>Jaffe</surname> <given-names>JD</given-names></name><name><surname>Shamji</surname> <given-names>AF</given-names></name><name><surname>Bhan</surname> <given-names>AK</given-names></name><name><surname>Carr</surname> <given-names>SA</given-names></name><name><surname>Daly</surname> <given-names>MJ</given-names></name><name><surname>Virgin</surname> <given-names>HW</given-names></name><name><surname>Schreiber</surname> <given-names>SL</given-names></name><name><surname>Stappenbeck</surname> <given-names>TS</given-names></name><name><surname>Xavier</surname> <given-names>RJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Atg16L1 T300A variant decreases selective autophagy resulting in altered cytokine signaling and decreased antibacterial defense</article-title><source>PNAS</source><volume>111</volume><fpage>7741</fpage><lpage>7746</lpage><pub-id pub-id-type="doi">10.1073/pnas.1407001111</pub-id><pub-id pub-id-type="pmid">24821797</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>J</given-names></name><name><surname>Doty</surname> <given-names>AL</given-names></name><name><surname>Tang</surname> <given-names>Y</given-names></name><name><surname>Berrie</surname> <given-names>D</given-names></name><name><surname>Iqbal</surname> <given-names>A</given-names></name><name><surname>Tan</surname> <given-names>SA</given-names></name><name><surname>Clare-Salzler</surname> <given-names>MJ</given-names></name><name><surname>Wallet</surname> <given-names>SM</given-names></name><name><surname>Glover</surname> <given-names>SC</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Enrichment of IL-17A+ IFN-γ+ and IL-22+ IFN-γ+ T cell subsets is associated with reduction of NKp44+ ILC3s in the terminal ileum of Crohn's disease patients</article-title><source>Clinical and Experimental Immunology</source><volume>190</volume><fpage>143</fpage><lpage>153</lpage><pub-id pub-id-type="doi">10.1111/cei.12996</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>JZ</given-names></name><name><surname>van Sommeren</surname> <given-names>S</given-names></name><name><surname>Huang</surname> <given-names>H</given-names></name><name><surname>Ng</surname> <given-names>SC</given-names></name><name><surname>Alberts</surname> <given-names>R</given-names></name><name><surname>Takahashi</surname> <given-names>A</given-names></name><name><surname>Ripke</surname> <given-names>S</given-names></name><name><surname>Lee</surname> <given-names>JC</given-names></name><name><surname>Jostins</surname> <given-names>L</given-names></name><name><surname>Shah</surname> <given-names>T</given-names></name><name><surname>Abedian</surname> <given-names>S</given-names></name><name><surname>Cheon</surname> <given-names>JH</given-names></name><name><surname>Cho</surname> <given-names>J</given-names></name><name><surname>Dayani</surname> <given-names>NE</given-names></name><name><surname>Franke</surname> <given-names>L</given-names></name><name><surname>Fuyuno</surname> <given-names>Y</given-names></name><name><surname>Hart</surname> <given-names>A</given-names></name><name><surname>Juyal</surname> <given-names>RC</given-names></name><name><surname>Juyal</surname> <given-names>G</given-names></name><name><surname>Kim</surname> <given-names>WH</given-names></name><name><surname>Morris</surname> <given-names>AP</given-names></name><name><surname>Poustchi</surname> <given-names>H</given-names></name><name><surname>Newman</surname> <given-names>WG</given-names></name><name><surname>Midha</surname> <given-names>V</given-names></name><name><surname>Orchard</surname> <given-names>TR</given-names></name><name><surname>Vahedi</surname> <given-names>H</given-names></name><name><surname>Sood</surname> <given-names>A</given-names></name><name><surname>Sung</surname> <given-names>JY</given-names></name><name><surname>Malekzadeh</surname> <given-names>R</given-names></name><name><surname>Westra</surname> <given-names>HJ</given-names></name><name><surname>Yamazaki</surname> <given-names>K</given-names></name><name><surname>Yang</surname> <given-names>SK</given-names></name><name><surname>Barrett</surname> <given-names>JC</given-names></name><name><surname>Alizadeh</surname> <given-names>BZ</given-names></name><name><surname>Parkes</surname> <given-names>M</given-names></name><name><surname>Bk</surname> <given-names>T</given-names></name><name><surname>Daly</surname> <given-names>MJ</given-names></name><name><surname>Kubo</surname> <given-names>M</given-names></name><name><surname>Anderson</surname> <given-names>CA</given-names></name><name><surname>Weersma</surname> <given-names>RK</given-names></name><collab>International Multiple Sclerosis Genetics Consortium</collab><collab>International IBD Genetics Consortium</collab></person-group><year iso-8601-date="2015">2015</year><article-title>Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations</article-title><source>Nature Genetics</source><volume>47</volume><fpage>979</fpage><lpage>986</lpage><pub-id pub-id-type="doi">10.1038/ng.3359</pub-id><pub-id pub-id-type="pmid">26192919</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lodes</surname> <given-names>MJ</given-names></name><name><surname>Cong</surname> <given-names>Y</given-names></name><name><surname>Elson</surname> <given-names>CO</given-names></name><name><surname>Mohamath</surname> <given-names>R</given-names></name><name><surname>Landers</surname> <given-names>CJ</given-names></name><name><surname>Targan</surname> <given-names>SR</given-names></name><name><surname>Fort</surname> <given-names>M</given-names></name><name><surname>Hershberg</surname> <given-names>RM</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Bacterial flagellin is a dominant antigen in Crohn disease</article-title><source>Journal of Clinical Investigation</source><volume>113</volume><fpage>1296</fpage><lpage>1306</lpage><pub-id pub-id-type="doi">10.1172/JCI200420295</pub-id><pub-id pub-id-type="pmid">15124021</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname> <given-names>Y</given-names></name><name><surname>de Lange</surname> <given-names>KM</given-names></name><name><surname>Jostins</surname> <given-names>L</given-names></name><name><surname>Moutsianas</surname> <given-names>L</given-names></name><name><surname>Randall</surname> <given-names>J</given-names></name><name><surname>Kennedy</surname> <given-names>NA</given-names></name><name><surname>Lamb</surname> <given-names>CA</given-names></name><name><surname>McCarthy</surname> <given-names>S</given-names></name><name><surname>Ahmad</surname> <given-names>T</given-names></name><name><surname>Edwards</surname> <given-names>C</given-names></name><name><surname>Serra</surname> <given-names>EG</given-names></name><name><surname>Hart</surname> <given-names>A</given-names></name><name><surname>Hawkey</surname> <given-names>C</given-names></name><name><surname>Mansfield</surname> <given-names>JC</given-names></name><name><surname>Mowat</surname> <given-names>C</given-names></name><name><surname>Newman</surname> <given-names>WG</given-names></name><name><surname>Nichols</surname> <given-names>S</given-names></name><name><surname>Pollard</surname> <given-names>M</given-names></name><name><surname>Satsangi</surname> <given-names>J</given-names></name><name><surname>Simmons</surname> <given-names>A</given-names></name><name><surname>Tremelling</surname> <given-names>M</given-names></name><name><surname>Uhlig</surname> <given-names>H</given-names></name><name><surname>Wilson</surname> <given-names>DC</given-names></name><name><surname>Lee</surname> <given-names>JC</given-names></name><name><surname>Prescott</surname> <given-names>NJ</given-names></name><name><surname>Lees</surname> <given-names>CW</given-names></name><name><surname>Mathew</surname> <given-names>CG</given-names></name><name><surname>Parkes</surname> <given-names>M</given-names></name><name><surname>Barrett</surname> <given-names>JC</given-names></name><name><surname>Anderson</surname> <given-names>CA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Exploring the genetic architecture of inflammatory bowel disease by whole-genome sequencing identifies association at ADCY7</article-title><source>Nature Genetics</source><volume>49</volume><fpage>186</fpage><lpage>192</lpage><pub-id pub-id-type="doi">10.1038/ng.3761</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manichanh</surname> <given-names>C</given-names></name><name><surname>Rigottier-Gois</surname> <given-names>L</given-names></name><name><surname>Bonnaud</surname> <given-names>E</given-names></name><name><surname>Gloux</surname> <given-names>K</given-names></name><name><surname>Pelletier</surname> <given-names>E</given-names></name><name><surname>Frangeul</surname> <given-names>L</given-names></name><name><surname>Nalin</surname> <given-names>R</given-names></name><name><surname>Jarrin</surname> <given-names>C</given-names></name><name><surname>Chardon</surname> <given-names>P</given-names></name><name><surname>Marteau</surname> <given-names>P</given-names></name><name><surname>Roca</surname> <given-names>J</given-names></name><name><surname>Dore</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach</article-title><source>Gut</source><volume>55</volume><fpage>205</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1136/gut.2005.073817</pub-id><pub-id pub-id-type="pmid">16188921</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McDonald</surname> <given-names>D</given-names></name><name><surname>Price</surname> <given-names>MN</given-names></name><name><surname>Goodrich</surname> <given-names>J</given-names></name><name><surname>Nawrocki</surname> <given-names>EP</given-names></name><name><surname>DeSantis</surname> <given-names>TZ</given-names></name><name><surname>Probst</surname> <given-names>A</given-names></name><name><surname>Andersen</surname> <given-names>GL</given-names></name><name><surname>Knight</surname> <given-names>R</given-names></name><name><surname>Hugenholtz</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea</article-title><source>The ISME Journal</source><volume>6</volume><fpage>610</fpage><lpage>618</lpage><pub-id pub-id-type="doi">10.1038/ismej.2011.139</pub-id><pub-id pub-id-type="pmid">22134646</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McIlrath</surname> <given-names>DC</given-names></name></person-group><year iso-8601-date="1971">1971</year><article-title>Diverting ileostomy or colostomy in the management of Crohn's disease of the colon</article-title><source>Archives of Surgery</source><volume>103</volume><fpage>308</fpage><lpage>310</lpage><pub-id pub-id-type="doi">10.1001/archsurg.1971.01350080224035</pub-id><pub-id pub-id-type="pmid">5562817</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morgan</surname> <given-names>XC</given-names></name><name><surname>Tickle</surname> <given-names>TL</given-names></name><name><surname>Sokol</surname> <given-names>H</given-names></name><name><surname>Gevers</surname> <given-names>D</given-names></name><name><surname>Devaney</surname> <given-names>KL</given-names></name><name><surname>Ward</surname> <given-names>DV</given-names></name><name><surname>Reyes</surname> <given-names>JA</given-names></name><name><surname>Shah</surname> <given-names>SA</given-names></name><name><surname>LeLeiko</surname> <given-names>N</given-names></name><name><surname>Snapper</surname> <given-names>SB</given-names></name><name><surname>Bousvaros</surname> <given-names>A</given-names></name><name><surname>Korzenik</surname> <given-names>J</given-names></name><name><surname>Sands</surname> <given-names>BE</given-names></name><name><surname>Xavier</surname> <given-names>RJ</given-names></name><name><surname>Huttenhower</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment</article-title><source>Genome Biology</source><volume>13</volume><fpage>R79</fpage><pub-id pub-id-type="doi">10.1186/gb-2012-13-9-r79</pub-id><pub-id pub-id-type="pmid">23013615</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moschen</surname> <given-names>AR</given-names></name><name><surname>Tilg</surname> <given-names>H</given-names></name><name><surname>Raine</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting</article-title><source>Nature Reviews Gastroenterology &amp; Hepatology</source><volume>314</volume><pub-id pub-id-type="doi">10.1038/s41575-018-0084-8</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moustafa</surname> <given-names>A</given-names></name><name><surname>Li</surname> <given-names>W</given-names></name><name><surname>Anderson</surname> <given-names>EL</given-names></name><name><surname>Wong</surname> <given-names>EHM</given-names></name><name><surname>Dulai</surname> <given-names>PS</given-names></name><name><surname>Sandborn</surname> <given-names>WJ</given-names></name><name><surname>Biggs</surname> <given-names>W</given-names></name><name><surname>Yooseph</surname> <given-names>S</given-names></name><name><surname>Jones</surname> <given-names>MB</given-names></name><name><surname>Venter</surname> <given-names>JC</given-names></name><name><surname>Nelson</surname> <given-names>KE</given-names></name><name><surname>Chang</surname> <given-names>JT</given-names></name><name><surname>Telenti</surname> <given-names>A</given-names></name><name><surname>Boland</surname> <given-names>BS</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Genetic risk, dysbiosis, and treatment stratification using host genome and gut microbiome in inflammatory bowel disease</article-title><source>Clinical and Translational Gastroenterology</source><volume>9</volume><elocation-id>e132</elocation-id><pub-id pub-id-type="doi">10.1038/ctg.2017.58</pub-id><pub-id pub-id-type="pmid">29345635</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murthy</surname> <given-names>A</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Peng</surname> <given-names>I</given-names></name><name><surname>Reichelt</surname> <given-names>M</given-names></name><name><surname>Katakam</surname> <given-names>AK</given-names></name><name><surname>Noubade</surname> <given-names>R</given-names></name><name><surname>Roose-Girma</surname> <given-names>M</given-names></name><name><surname>DeVoss</surname> <given-names>J</given-names></name><name><surname>Diehl</surname> <given-names>L</given-names></name><name><surname>Graham</surname> <given-names>RR</given-names></name><name><surname>van Lookeren Campagne</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A Crohn's disease variant in Atg16l1 enhances its degradation by caspase 3</article-title><source>Nature</source><volume>506</volume><fpage>456</fpage><lpage>462</lpage><pub-id pub-id-type="doi">10.1038/nature13044</pub-id><pub-id pub-id-type="pmid">24553140</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ott</surname> <given-names>SJ</given-names></name><name><surname>Musfeldt</surname> <given-names>M</given-names></name><name><surname>Wenderoth</surname> <given-names>DF</given-names></name><name><surname>Hampe</surname> <given-names>J</given-names></name><name><surname>Brant</surname> <given-names>O</given-names></name><name><surname>Fölsch</surname> <given-names>UR</given-names></name><name><surname>Timmis</surname> <given-names>KN</given-names></name><name><surname>Schreiber</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease</article-title><source>Gut</source><volume>53</volume><fpage>685</fpage><lpage>693</lpage><pub-id pub-id-type="doi">10.1136/gut.2003.025403</pub-id><pub-id pub-id-type="pmid">15082587</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palm</surname> <given-names>NW</given-names></name><name><surname>de Zoete</surname> <given-names>MR</given-names></name><name><surname>Flavell</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Immune-microbiota interactions in health and disease</article-title><source>Clinical Immunology</source><volume>159</volume><fpage>122</fpage><lpage>127</lpage><pub-id pub-id-type="doi">10.1016/j.clim.2015.05.014</pub-id><pub-id pub-id-type="pmid">26141651</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pantosti</surname> <given-names>A</given-names></name><name><surname>Tzianabos</surname> <given-names>AO</given-names></name><name><surname>Onderdonk</surname> <given-names>AB</given-names></name><name><surname>Kasper</surname> <given-names>DL</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Immunochemical characterization of two surface polysaccharides of Bacteroides fragilis</article-title><source>Infection and Immunity</source><volume>59</volume><fpage>2075</fpage><lpage>2082</lpage><pub-id pub-id-type="pmid">2037368</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parronchi</surname> <given-names>P</given-names></name><name><surname>Romagnani</surname> <given-names>P</given-names></name><name><surname>Annunziato</surname> <given-names>F</given-names></name><name><surname>Sampognaro</surname> <given-names>S</given-names></name><name><surname>Becchio</surname> <given-names>A</given-names></name><name><surname>Giannarini</surname> <given-names>L</given-names></name><name><surname>Maggi</surname> <given-names>E</given-names></name><name><surname>Pupilli</surname> <given-names>C</given-names></name><name><surname>Tonelli</surname> <given-names>F</given-names></name><name><surname>Romagnani</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease</article-title><source>The American Journal of Pathology</source><volume>150</volume><fpage>823</fpage><lpage>832</lpage><pub-id pub-id-type="pmid">9060820</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Podolsky</surname> <given-names>DK</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Inflammatory bowel disease</article-title><source>New England Journal of Medicine</source><volume>347</volume><fpage>417</fpage><lpage>429</lpage><pub-id pub-id-type="doi">10.1056/NEJMra020831</pub-id><pub-id pub-id-type="pmid">12167685</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajilić-Stojanović</surname> <given-names>M</given-names></name><name><surname>Shanahan</surname> <given-names>F</given-names></name><name><surname>Guarner</surname> <given-names>F</given-names></name><name><surname>de Vos</surname> <given-names>WM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Phylogenetic analysis of dysbiosis in ulcerative colitis during remission</article-title><source>Inflammatory Bowel Diseases</source><volume>19</volume><fpage>481</fpage><lpage>488</lpage><pub-id pub-id-type="doi">10.1097/MIB.0b013e31827fec6d</pub-id><pub-id pub-id-type="pmid">23385241</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramanan</surname> <given-names>D</given-names></name><name><surname>Tang</surname> <given-names>MS</given-names></name><name><surname>Bowcutt</surname> <given-names>R</given-names></name><name><surname>Loke</surname> <given-names>P</given-names></name><name><surname>Cadwell</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Bacterial sensor Nod2 prevents inflammation of the small intestine by restricting the expansion of the commensal Bacteroides vulgatus</article-title><source>Immunity</source><volume>41</volume><fpage>311</fpage><lpage>324</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2014.06.015</pub-id><pub-id pub-id-type="pmid">25088769</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rehman</surname> <given-names>A</given-names></name><name><surname>Lepage</surname> <given-names>P</given-names></name><name><surname>Nolte</surname> <given-names>A</given-names></name><name><surname>Hellmig</surname> <given-names>S</given-names></name><name><surname>Schreiber</surname> <given-names>S</given-names></name><name><surname>Ott</surname> <given-names>SJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Transcriptional activity of the dominant gut mucosal microbiota in chronic inflammatory bowel disease patients</article-title><source>Journal of Medical Microbiology</source><volume>59</volume><fpage>1114</fpage><lpage>1122</lpage><pub-id pub-id-type="doi">10.1099/jmm.0.021170-0</pub-id><pub-id pub-id-type="pmid">20522625</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rioux</surname> <given-names>JD</given-names></name><name><surname>Xavier</surname> <given-names>RJ</given-names></name><name><surname>Taylor</surname> <given-names>KD</given-names></name><name><surname>Silverberg</surname> <given-names>MS</given-names></name><name><surname>Goyette</surname> <given-names>P</given-names></name><name><surname>Huett</surname> <given-names>A</given-names></name><name><surname>Green</surname> <given-names>T</given-names></name><name><surname>Kuballa</surname> <given-names>P</given-names></name><name><surname>Barmada</surname> <given-names>MM</given-names></name><name><surname>Datta</surname> <given-names>LW</given-names></name><name><surname>Shugart</surname> <given-names>YY</given-names></name><name><surname>Griffiths</surname> <given-names>AM</given-names></name><name><surname>Targan</surname> <given-names>SR</given-names></name><name><surname>Ippoliti</surname> <given-names>AF</given-names></name><name><surname>Bernard</surname> <given-names>EJ</given-names></name><name><surname>Mei</surname> <given-names>L</given-names></name><name><surname>Nicolae</surname> <given-names>DL</given-names></name><name><surname>Regueiro</surname> <given-names>M</given-names></name><name><surname>Schumm</surname> <given-names>LP</given-names></name><name><surname>Steinhart</surname> <given-names>AH</given-names></name><name><surname>Rotter</surname> <given-names>JI</given-names></name><name><surname>Duerr</surname> <given-names>RH</given-names></name><name><surname>Cho</surname> <given-names>JH</given-names></name><name><surname>Daly</surname> <given-names>MJ</given-names></name><name><surname>Brant</surname> <given-names>SR</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis</article-title><source>Nature Genetics</source><volume>39</volume><fpage>596</fpage><lpage>604</lpage><pub-id pub-id-type="doi">10.1038/ng2032</pub-id><pub-id pub-id-type="pmid">17435756</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ritchie</surname> <given-names>ME</given-names></name><name><surname>Phipson</surname> <given-names>B</given-names></name><name><surname>Wu</surname> <given-names>D</given-names></name><name><surname>Hu</surname> <given-names>Y</given-names></name><name><surname>Law</surname> <given-names>CW</given-names></name><name><surname>Shi</surname> <given-names>W</given-names></name><name><surname>Smyth</surname> <given-names>GK</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>limma powers differential expression analyses for RNA-sequencing and microarray studies</article-title><source>Nucleic Acids Research</source><volume>43</volume><fpage>e47</fpage><pub-id pub-id-type="doi">10.1093/nar/gkv007</pub-id><pub-id pub-id-type="pmid">25605792</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rooks</surname> <given-names>MG</given-names></name><name><surname>Veiga</surname> <given-names>P</given-names></name><name><surname>Wardwell-Scott</surname> <given-names>LH</given-names></name><name><surname>Tickle</surname> <given-names>T</given-names></name><name><surname>Segata</surname> <given-names>N</given-names></name><name><surname>Michaud</surname> <given-names>M</given-names></name><name><surname>Gallini</surname> <given-names>CA</given-names></name><name><surname>Beal</surname> <given-names>C</given-names></name><name><surname>van Hylckama-Vlieg</surname> <given-names>JE</given-names></name><name><surname>Ballal</surname> <given-names>SA</given-names></name><name><surname>Morgan</surname> <given-names>XC</given-names></name><name><surname>Glickman</surname> <given-names>JN</given-names></name><name><surname>Gevers</surname> <given-names>D</given-names></name><name><surname>Huttenhower</surname> <given-names>C</given-names></name><name><surname>Garrett</surname> <given-names>WS</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Gut microbiome composition and function in experimental colitis during active disease and treatment-induced remission</article-title><source>The ISME Journal</source><volume>8</volume><fpage>1403</fpage><lpage>1417</lpage><pub-id pub-id-type="doi">10.1038/ismej.2014.3</pub-id><pub-id pub-id-type="pmid">24500617</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rutgeerts</surname> <given-names>P</given-names></name><name><surname>Goboes</surname> <given-names>K</given-names></name><name><surname>Peeters</surname> <given-names>M</given-names></name><name><surname>Hiele</surname> <given-names>M</given-names></name><name><surname>Penninckx</surname> <given-names>F</given-names></name><name><surname>Aerts</surname> <given-names>R</given-names></name><name><surname>Kerremans</surname> <given-names>R</given-names></name><name><surname>Vantrappen</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum</article-title><source>The Lancet</source><volume>338</volume><fpage>771</fpage><lpage>774</lpage><pub-id pub-id-type="doi">10.1016/0140-6736(91)90663-A</pub-id><pub-id pub-id-type="pmid">1681159</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saitoh</surname> <given-names>T</given-names></name><name><surname>Fujita</surname> <given-names>N</given-names></name><name><surname>Jang</surname> <given-names>MH</given-names></name><name><surname>Uematsu</surname> <given-names>S</given-names></name><name><surname>Yang</surname> <given-names>BG</given-names></name><name><surname>Satoh</surname> <given-names>T</given-names></name><name><surname>Omori</surname> <given-names>H</given-names></name><name><surname>Noda</surname> <given-names>T</given-names></name><name><surname>Yamamoto</surname> <given-names>N</given-names></name><name><surname>Komatsu</surname> <given-names>M</given-names></name><name><surname>Tanaka</surname> <given-names>K</given-names></name><name><surname>Kawai</surname> <given-names>T</given-names></name><name><surname>Tsujimura</surname> <given-names>T</given-names></name><name><surname>Takeuchi</surname> <given-names>O</given-names></name><name><surname>Yoshimori</surname> <given-names>T</given-names></name><name><surname>Akira</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production</article-title><source>Nature</source><volume>456</volume><fpage>264</fpage><lpage>268</lpage><pub-id pub-id-type="doi">10.1038/nature07383</pub-id><pub-id pub-id-type="pmid">18849965</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakamoto</surname> <given-names>M</given-names></name><name><surname>Ohkuma</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Identification and classification of the genus Bacteroides by multilocus sequence analysis</article-title><source>Microbiology</source><volume>157</volume><fpage>3388</fpage><lpage>3397</lpage><pub-id pub-id-type="doi">10.1099/mic.0.052332-0</pub-id><pub-id pub-id-type="pmid">21948050</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sartor</surname> <given-names>RB</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Microbial influences in inflammatory bowel diseases</article-title><source>Gastroenterology</source><volume>134</volume><fpage>577</fpage><lpage>594</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2007.11.059</pub-id><pub-id pub-id-type="pmid">18242222</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sellon</surname> <given-names>RK</given-names></name><name><surname>Tonkonogy</surname> <given-names>S</given-names></name><name><surname>Schultz</surname> <given-names>M</given-names></name><name><surname>Dieleman</surname> <given-names>LA</given-names></name><name><surname>Grenther</surname> <given-names>W</given-names></name><name><surname>Balish</surname> <given-names>E</given-names></name><name><surname>Rennick</surname> <given-names>DM</given-names></name><name><surname>Sartor</surname> <given-names>RB</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice</article-title><source>Infection and Immunity</source><volume>66</volume><fpage>5224</fpage><lpage>5231</lpage><pub-id pub-id-type="pmid">9784526</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swidsinski</surname> <given-names>A</given-names></name><name><surname>Ladhoff</surname> <given-names>A</given-names></name><name><surname>Pernthaler</surname> <given-names>A</given-names></name><name><surname>Swidsinski</surname> <given-names>S</given-names></name><name><surname>Loening-Baucke</surname> <given-names>V</given-names></name><name><surname>Ortner</surname> <given-names>M</given-names></name><name><surname>Weber</surname> <given-names>J</given-names></name><name><surname>Hoffmann</surname> <given-names>U</given-names></name><name><surname>Schreiber</surname> <given-names>S</given-names></name><name><surname>Dietel</surname> <given-names>M</given-names></name><name><surname>Lochs</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Mucosal flora in inflammatory bowel disease</article-title><source>Gastroenterology</source><volume>122</volume><fpage>44</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1053/gast.2002.30294</pub-id><pub-id pub-id-type="pmid">11781279</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swidsinski</surname> <given-names>A</given-names></name><name><surname>Weber</surname> <given-names>J</given-names></name><name><surname>Loening-Baucke</surname> <given-names>V</given-names></name><name><surname>Hale</surname> <given-names>LP</given-names></name><name><surname>Lochs</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease</article-title><source>Journal of Clinical Microbiology</source><volume>43</volume><fpage>3380</fpage><lpage>3389</lpage><pub-id pub-id-type="doi">10.1128/JCM.43.7.3380-3389.2005</pub-id><pub-id pub-id-type="pmid">16000463</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname> <given-names>TG</given-names></name><name><surname>Sefik</surname> <given-names>E</given-names></name><name><surname>Geva-Zatorsky</surname> <given-names>N</given-names></name><name><surname>Kua</surname> <given-names>L</given-names></name><name><surname>Naskar</surname> <given-names>D</given-names></name><name><surname>Teng</surname> <given-names>F</given-names></name><name><surname>Pasman</surname> <given-names>L</given-names></name><name><surname>Ortiz-Lopez</surname> <given-names>A</given-names></name><name><surname>Jupp</surname> <given-names>R</given-names></name><name><surname>Wu</surname> <given-names>HJ</given-names></name><name><surname>Kasper</surname> <given-names>DL</given-names></name><name><surname>Benoist</surname> <given-names>C</given-names></name><name><surname>Mathis</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Identifying species of symbiont bacteria from the human gut that, alone, can induce intestinal Th17 cells in mice</article-title><source>PNAS</source><volume>113</volume><fpage>E8141</fpage><lpage>E8150</lpage><pub-id pub-id-type="doi">10.1073/pnas.1617460113</pub-id><pub-id pub-id-type="pmid">27911839</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Travassos</surname> <given-names>LH</given-names></name><name><surname>Carneiro</surname> <given-names>LA</given-names></name><name><surname>Ramjeet</surname> <given-names>M</given-names></name><name><surname>Hussey</surname> <given-names>S</given-names></name><name><surname>Kim</surname> <given-names>YG</given-names></name><name><surname>Magalhães</surname> <given-names>JG</given-names></name><name><surname>Yuan</surname> <given-names>L</given-names></name><name><surname>Soares</surname> <given-names>F</given-names></name><name><surname>Chea</surname> <given-names>E</given-names></name><name><surname>Le Bourhis</surname> <given-names>L</given-names></name><name><surname>Boneca</surname> <given-names>IG</given-names></name><name><surname>Allaoui</surname> <given-names>A</given-names></name><name><surname>Jones</surname> <given-names>NL</given-names></name><name><surname>Nuñez</surname> <given-names>G</given-names></name><name><surname>Girardin</surname> <given-names>SE</given-names></name><name><surname>Philpott</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry</article-title><source>Nature Immunology</source><volume>11</volume><fpage>55</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1038/ni.1823</pub-id><pub-id pub-id-type="pmid">19898471</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Truong</surname> <given-names>DT</given-names></name><name><surname>Franzosa</surname> <given-names>EA</given-names></name><name><surname>Tickle</surname> <given-names>TL</given-names></name><name><surname>Scholz</surname> <given-names>M</given-names></name><name><surname>Weingart</surname> <given-names>G</given-names></name><name><surname>Pasolli</surname> <given-names>E</given-names></name><name><surname>Tett</surname> <given-names>A</given-names></name><name><surname>Huttenhower</surname> <given-names>C</given-names></name><name><surname>Segata</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>MetaPhlAn2 for enhanced metagenomic taxonomic profiling</article-title><source>Nature Methods</source><volume>12</volume><fpage>902</fpage><lpage>903</lpage><pub-id pub-id-type="doi">10.1038/nmeth.3589</pub-id><pub-id pub-id-type="pmid">26418763</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turpin</surname> <given-names>W</given-names></name><name><surname>Goethel</surname> <given-names>A</given-names></name><name><surname>Bedrani</surname> <given-names>L</given-names></name><name><surname>Croitoru Mdcm</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Determinants of IBD Heritability: Genes, Bugs, and More</article-title><source>Inflammatory bowel diseases</source><volume>24</volume><fpage>577</fpage><lpage>1148</lpage><pub-id pub-id-type="doi">10.1093/ibd/izy085</pub-id><pub-id pub-id-type="pmid">29701818</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willing</surname> <given-names>B</given-names></name><name><surname>Halfvarson</surname> <given-names>J</given-names></name><name><surname>Dicksved</surname> <given-names>J</given-names></name><name><surname>Rosenquist</surname> <given-names>M</given-names></name><name><surname>Järnerot</surname> <given-names>G</given-names></name><name><surname>Engstrand</surname> <given-names>L</given-names></name><name><surname>Tysk</surname> <given-names>C</given-names></name><name><surname>Jansson</surname> <given-names>JK</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease</article-title><source>Inflammatory Bowel Diseases</source><volume>15</volume><fpage>653</fpage><lpage>660</lpage><pub-id pub-id-type="doi">10.1002/ibd.20783</pub-id><pub-id pub-id-type="pmid">19023901</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xavier</surname> <given-names>RJ</given-names></name><name><surname>Podolsky</surname> <given-names>DK</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Unravelling the pathogenesis of inflammatory bowel disease</article-title><source>Nature</source><volume>448</volume><fpage>427</fpage><lpage>434</lpage><pub-id pub-id-type="doi">10.1038/nature06005</pub-id><pub-id pub-id-type="pmid">17653185</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yen</surname> <given-names>D</given-names></name><name><surname>Cheung</surname> <given-names>J</given-names></name><name><surname>Scheerens</surname> <given-names>H</given-names></name><name><surname>Poulet</surname> <given-names>F</given-names></name><name><surname>McClanahan</surname> <given-names>T</given-names></name><name><surname>McKenzie</surname> <given-names>B</given-names></name><name><surname>Kleinschek</surname> <given-names>MA</given-names></name><name><surname>Owyang</surname> <given-names>A</given-names></name><name><surname>Mattson</surname> <given-names>J</given-names></name><name><surname>Blumenschein</surname> <given-names>W</given-names></name><name><surname>Murphy</surname> <given-names>E</given-names></name><name><surname>Sathe</surname> <given-names>M</given-names></name><name><surname>Cua</surname> <given-names>DJ</given-names></name><name><surname>Kastelein</surname> <given-names>RA</given-names></name><name><surname>Rennick</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6</article-title><source>Journal of Clinical Investigation</source><volume>116</volume><fpage>1310</fpage><lpage>1316</lpage><pub-id pub-id-type="doi">10.1172/JCI21404</pub-id><pub-id pub-id-type="pmid">16670770</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>H</given-names></name><name><surname>Zheng</surname> <given-names>L</given-names></name><name><surname>McGovern</surname> <given-names>DPB</given-names></name><name><surname>Hamill</surname> <given-names>AM</given-names></name><name><surname>Ichikawa</surname> <given-names>R</given-names></name><name><surname>Kanazawa</surname> <given-names>Y</given-names></name><name><surname>Luu</surname> <given-names>J</given-names></name><name><surname>Kumagai</surname> <given-names>K</given-names></name><name><surname>Cilluffo</surname> <given-names>M</given-names></name><name><surname>Fukata</surname> <given-names>M</given-names></name><name><surname>Targan</surname> <given-names>SR</given-names></name><name><surname>Underhill</surname> <given-names>DM</given-names></name><name><surname>Zhang</surname> <given-names>X</given-names></name><name><surname>Shih</surname> <given-names>DQ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Myeloid ATG16L1 Facilitates Host–Bacteria Interactions in Maintaining Intestinal Homeostasis</article-title><source>The Journal of Immunology</source><volume>198</volume><fpage>2133</fpage><lpage>2146</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1601293</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhernakova</surname> <given-names>A</given-names></name><name><surname>Kurilshikov</surname> <given-names>A</given-names></name><name><surname>Bonder</surname> <given-names>MJ</given-names></name><name><surname>Tigchelaar</surname> <given-names>EF</given-names></name><name><surname>Schirmer</surname> <given-names>M</given-names></name><name><surname>Vatanen</surname> <given-names>T</given-names></name><name><surname>Mujagic</surname> <given-names>Z</given-names></name><name><surname>Vila</surname> <given-names>AV</given-names></name><name><surname>Falony</surname> <given-names>G</given-names></name><name><surname>Vieira-Silva</surname> <given-names>S</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Imhann</surname> <given-names>F</given-names></name><name><surname>Brandsma</surname> <given-names>E</given-names></name><name><surname>Jankipersadsing</surname> <given-names>SA</given-names></name><name><surname>Joossens</surname> <given-names>M</given-names></name><name><surname>Cenit</surname> <given-names>MC</given-names></name><name><surname>Deelen</surname> <given-names>P</given-names></name><name><surname>Swertz</surname> <given-names>MA</given-names></name><name><surname>Weersma</surname> <given-names>RK</given-names></name><name><surname>Feskens</surname> <given-names>EJ</given-names></name><name><surname>Netea</surname> <given-names>MG</given-names></name><name><surname>Gevers</surname> <given-names>D</given-names></name><name><surname>Jonkers</surname> <given-names>D</given-names></name><name><surname>Franke</surname> <given-names>L</given-names></name><name><surname>Aulchenko</surname> <given-names>YS</given-names></name><name><surname>Huttenhower</surname> <given-names>C</given-names></name><name><surname>Raes</surname> <given-names>J</given-names></name><name><surname>Hofker</surname> <given-names>MH</given-names></name><name><surname>Xavier</surname> <given-names>RJ</given-names></name><name><surname>Wijmenga</surname> <given-names>C</given-names></name><name><surname>Fu</surname> <given-names>J</given-names></name><collab>LifeLines cohort study</collab></person-group><year iso-8601-date="2016">2016</year><article-title>Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity</article-title><source>Science</source><volume>352</volume><fpage>565</fpage><lpage>569</lpage><pub-id pub-id-type="doi">10.1126/science.aad3369</pub-id><pub-id pub-id-type="pmid">27126040</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="SA1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.39982.033</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Cadwell</surname><given-names>Ken H</given-names></name><role>Reviewing Editor</role><aff><institution>Skirball Institute of Biomolecular Health</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.</p></boxed-text><p>Thank you for sending your article entitled &quot;The Crohn's disease polymorphism, <italic>ATG16L1T300A</italic>, alters the gut microbiota and enhances the local Th1/Th17 response&quot; for peer review at <italic>eLife</italic>. Your article is being evaluated by three peer reviewers, and the evaluation is being overseen by a Reviewing Editor and Tadatsugu Taniguchi as the Senior Editor.</p><p>As you will see, there is consensus among the reviewers that the conclusions of the manuscript, if valid, are of great interest to the field and appropriate for publication in <italic>eLife</italic>. The reviewers and the Reviewing Editor all agree that the strength of the manuscript is the approach, where human IBD specimens are transferred into germ-free mice to reveal new gene-microbiome interactions. However, the absence of certain information, conditions, and controls calls into question the conclusions. The reason why certain data is missing in this study is likely due to the technically challenging and time consuming nature of this powerful approach. The reviewers are sympathetic to this challenge, and wish to give the authors an opportunity to respond. The following appear to be the big picture consensus concerns:</p><p>1) Analysis of the microbiome composition pre-DSS (or no DSS) is necessary to interpret the findings post-DSS.</p><p>2) The rationale for donor selection is unclear and potentially problematic. The non-T300A donors may be key to interpretation of the experiments and establishing baseline. Similarly, the T300A genotype does not appear to have a contribution towards microbiome composition in UC, although we cannot say that for sure with the current analysis. It is unclear mechanistically why it matters whether the sample is from UC vs CD with the same genotype. Also, why is the healthy control heterozygous for T300A? A related issue is the low N number for human donors. These differences between conditions (health status and genotype) may be a reflection of random donor heterogeneity.</p><p>3) A more thorough examination of the immune compartment is needed. There is a sense that the authors are finding what they're looking for.</p><p>4) Details regarding co-housing, gender, and littermates are missing. Depending on how the experiments were performed, a subset may need to be repeated under appropriate conditions to validate the initial findings.</p><p>If certain samples are readily available, and some of the concerns can be addressed through clarification of text rather than time-consuming experiment, then it may be possible to address these issues within the 2-month review period. The danger is that the authors will invest significant resources to improve the manuscript, only to find that the strategy is insufficient. Therefore, the editors and reviewers wish to invite you to respond within the next two weeks with an action plan and detailed timetable for the completion of the additional work. Please clearly state which issues will be addressed through writing versus generating new experimental results. Also, the above 4 points represent a summary of the discussion and we encourage you to carefully read and consider the detailed comments by the reviewers outlined below. We plan to share your responses with the reviewers and then issue a binding recommendation.</p><p><italic>Reviewer #1:</italic> </p><p>The Crohn disease risk allele ATG16L1 (<italic>ATG16L1T300A</italic>), which impacts expression of this important protein has known impacts on host immune response and results in decreased autophagy, increased pro-inflammatory cytokine release, and decreased intracellular bacterial clearance. This submitted manuscript addresses the major existing knowledge gaps regarding whether this and other genetic risk loci for IBD can also drive changes in the gut microbiota.</p><p>In this interesting work, the authors have studied a gnotobiotic model using patient fecal transfers in mice, bearing this same risk allele <italic>ATG16L1T300A</italic>, and determine the effects on host-microbiota interactions. Well-designed experiments reveal putative increases in certain bacteria – viz. <italic>Bacteroides ovatus</italic> as well as alterations in gut Th1/Th17 cells in <italic>ATG16L1T300A</italic> mice, without colitis possibly prior to disease onset.</p><p>Critique:</p><p>1) GWAS studies have linked over 230 genetic risk loci to increased IBD risk but this manuscript addresses only one and even when transferring stool from active Crohn disease patient does not cause experimental colitis per se. Further, already published work has shown that NOD2 variants, which may interact in aberrant manner with ATG16L1, predispose to dysbiosis – see Knights et al., 2014.</p><p>2) Alterations in mouse fecal microbiota are only noted in in SPF T300A vs. WT mice following on the generation of gut inflammation, as in Figure 1. It appears that the T300A risk allele may specifically enhance <italic>Bacteroides</italic> spp.</p><p>3) Data on the basal microbiome are not provided in quiescent &quot;control&quot; state given that T300A mice do not spontaneously develop intestinal inflammation.</p><p>4) In Figure 2, concise data indicate stability of microbiome diversity and changes in control and mutant mice, as dictated by human donor stool status. It is unclear why the healthy volunteer is in fact genotype heterozygous T300A (AG), when even the intermediate phenotype appears to impact the microbiome? Could this be addressed?</p><p>5) In Figure 3, the authors show increase in <italic>Bacteroides</italic> in T300A mice that received stool from active Crohn disease, and there are little changes noted in mice receiving stool from active UC patient. Test samples are from small numbers (n=1) of patients, as alluded to by authors.</p><p>6) Interestingly, T300A selectively appears to impact gut T cell populations in mice receiving Crohn disease stool (Figure 4) albeit there is no disease induction. In all mice, stool from all sources appears to increase T cells, relative to germ free mice but there are no RORγt T cells increments. There is no substantive colitis induced by donor stool transfer in the experiments reported –Figure 6—figure supplement 3.</p><p>7) Patient genotype data and stool microbiome data available from Jostins et al. in ref. 7, suggest that T300A in humans conveys a trend to increase <italic>Bacteroides</italic> fragilis, but not robustly with respect to the genus <italic>Bacteroides</italic> and not in a generally significant manner. (Figure 5). The authors suggest that T300A seems to reconfigure the human microbiota and importantly even the presence of a heterozygous genotype displays an intermediate phenotype with respect to <italic>Bacteroides</italic> species.</p><p>This current work has certain limitations as noted above, but is an important step as it provides insight into disease subtypes and has identified dysbiosis linked to genetics, which may impact future treatment avenues for IBD patients as well as informing diagnostic tests.</p><p><italic>Reviewer #2:</italic> </p><p>The study by Lavoie et al. explores the interaction between host genetics and the microbiome in inflammatory bowel disease using gnotobiotic T300A mice transplanted with genotyped IBD patient fecal material. Conceptually, this is an important area of investigation as previous studies focused primarily on either the microbial communities of IBD patients, or the role of host genes in modulating SPF microbiota in ATG16L1-deficient or T300A mice. The strength with this study is in combining the relevant microbiome samples (T300A CD vs healthy) in a relevant mouse model (T300A knockin mice) – however, several key details are still unresolved:</p><p>Major points include:</p><p>1) After 7 days of DSS, followed by 7 days of water is there a difference in weight loss or rebound kinetics between WT and T300A mice? Microbiome analysis pre-DSS colitis would be helpful to support the data in Figure 1, and can be provided as supplemental material.</p><p>The differences in microbial communities during inflammation between WT vs T300A mice are intriguing. However, during steady-state (no DSS) conditions, how do the microbiome compare? Are the differences observed during DSS colitis also present during naïve conditions? Is the bloom in <italic>Bacteroides</italic> due to DSS and inflammation? The authors state that these &quot;changes occur before the onset of disease, suggesting that ATG16L1 T300A may contribute initially to dysbiosis […]&quot; – if this is the case, do you observe increased <italic>Bacteroides</italic> before DSS colitis induction?</p><p>This is important since the following figure (Figure 2) show distinct communities between WT vs T300A recipient mice upon transplantation with CD active microbiota, conceivably in an inflammatory setting analogous to DSS conditions of Figure 1.</p><p>2) Along the same lines, do you observe an enrichment of <italic>Bacteroides</italic> spp. in CD active donor samples (in T300A or WT recipients) vs. CD inactive donor samples? The UC controls are informative, but how does CD active compare to CD inactive in respects to <italic>Bacteroides</italic> abundance?</p><p>3) The donors from healthy control and CD patients were nicely controlled, with all donors with T300A genotype. Were any experiments performed with T300 donors (healthy/CD active/CD inactive)? If so, how do they compare in the analysis in PCA plots (Figure 2A)? It appears that host genotype (T300A) of donor alone is not sufficient drive changes in the composition of the microbiota, as both WT and T300A mice cluster closely together when colonized with active UC T300A donors but not active CD T300A donors (Figure 2B).</p><p>Additionally, the authors note that &quot;the differences in the active CD microbiota in mice are due to the presence of the risk allele T300A as opposed to microbial population drift due to human stool transfer into mice alone&quot; – if this is the case, would the authors predict that T300 donors with active CD result in no differences when transplanted into WT and T300A recipient mice? This control would also be relevant when examining <italic>Bacteroides</italic> abundance to support the claim that &quot;T300A has the potential to drive increases in <italic>Bacteroides</italic> spp.&quot;. Perhaps the authors can refer to the data in Figure 5, and look at animals colonized with WT or Het to compare with T300A samples.</p><p>4) In Figure 2B, how does the microbiome of WT and T300A recipients (CD or UC) compare to the initial donor sample? Is there more drift in one genotype vs. the other?</p><p>5) In Figure 3, is the &quot;enrichment&quot; of <italic>Bacteroides</italic> in T300A mice with active CD microbiota truly due to T300A genotype driving the increase in <italic>Bacteroides</italic>? It's not clear if the abundance is relative or absolute, and can be compared with the Active UC donors, which appears to be at the same level as T300A Active CD mice. If so, are WT mice with active CD better able to control <italic>Bacteroides</italic> abundance?</p><p><italic>Reviewer #3:</italic> </p><p>Lavoie et al. investigate the contribution of germline variation in the core autophagy gene Atg16L1 (Thr300Ala) to intestinal dysbiosis in murine models. This approach reveals how variants significantly associated with inflammatory bowel disease can impact the microbiome even in the absence of overt disease pathology. Overall, the study is a thorough description of the changes that occur in the T300A mice, both at the level of flora and T cell phenotypes. While the datasets detailing microbial dysbiosis is novel and compelling, the study remains incomplete in a few aspects (detailed below, by Figure). Addressing these would significantly elevate the impact of the manuscript while furthering our understanding of how the T300A genotype impacts intestinal immune cell make-up. It would also provide the level of insight necessary for publication in <italic>eLife</italic>. The suggestions listed attempt to be mindful of the scope and resources within the current article.</p><p>Major comments:</p><p>Figure 1:</p><p>– Analysis of microbial diversity in animal studies is complex and requires thorough description of the approach used. While the figure and legend provide some level of detail, it would be useful to more clearly state if animals were gender matched, if there was a gender bias observed.</p><p>– Why did authors use 3 mice in WT group that were not cage matched to T300A mutants. (Figure 1A)? The Z-scores (and dendograms) may be driven by these 3 controls that are not ideal for a 16S sequencing study. Do the associations remain if only co-housed mice are re-analyzed?</p><p>– Given the strong association of the T300A variant with ileal Crohn's disease, why was ileal &quot;fecal&quot; content not assessed in this study? An attempt to perform this analysis, or a clear rationale as to why it wasn't attempted would benefit the reader.</p><p>Figure 2:</p><p>– Details regarding co-housing and gender(s) used, along with any gender bias if observed, would benefit the reader again. Were all recipients co-housed (either in pairs or other protocols) throughout the study?</p><p>Figure 4:</p><p>– What are the baseline alterations in gut immune cell populations in conventionally co-housed WT vs. T300A mice (from Figure 1)?</p><p>– Is the impact on Th1/Th17 abundance cell autonomous? Would adoptive transfer of T300A T cells into a WT recipient reproduce this phenotype? If not, it is an interesting observation as well since it would implicate additional host factors in driving T cell polarization.</p><p>– Authors only assessed specific T cell subsets, while the T300A genotype is germline. How does the T300A genotype impact abundance and/or function of other immune cell subsets relevant to IBD? Presenting data on Treg, NK/NKT, gdTcells or other tissue resident T cells, macrophage/monocyte, dendritic cell and B cell populations would be highly relevant.</p><p>– Given the expansion of RORc<sup>+</sup> CD4<sup>+</sup> T cells in the ileum lamina propria, are IL-23 producing DCs or myeloid cells overabundant? A simple measurement of IL12/23 family cytokines from intestinal explants in this study may provide the answer.</p><p>Figure 5:</p><p>– A discussion on how the observed dysbiosis may reflect on ileal flora would be useful here, given that the T300A variant is strongly associated with ileal CD.</p></body></sub-article><sub-article article-type="reply" id="SA2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.39982.034</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><p>[Editors' note: the authors’ plan for revisions was approved and the authors made a formal revised submission.]</p><disp-quote content-type="editor-comment"><p>As you will see, there is consensus among the reviewers that the conclusions of the manuscript, if valid, are of great interest to the field and appropriate for publication in eLife. The reviewers and the Reviewing Editor all agree that the strength of the manuscript is the approach, where human IBD specimens are transferred into germ-free mice to reveal new gene-microbiome interactions. However, the absence of certain information, conditions, and controls calls into question the conclusions. The reason why certain data is missing in this study is likely due to the technically challenging and time consuming nature of this powerful approach. The reviewers are sympathetic to this challenge, and wish to give the authors an opportunity to respond. The following appear to be the big picture consensus concerns:</p><p>1) Analysis of the microbiome composition pre-DSS (or no DSS) is necessary to interpret the findings post-DSS.</p></disp-quote><p>We agree with the reviewers’ concerns and think this is an important control missing from the work provided upon initial submission. We have analyzed stool samples by 16S rRNA gene amplicon sequencing from conventionally-housed, specific pathogen free (SPF) WT and T300A knockin mice under steady state conditions without DSS treatment. These data are now found in Figure 1. We can confirm from our data (histology – colitis scores of zero from the colons of SPF T300A mice) that these mice do not present with colitis under these conditions.</p><disp-quote content-type="editor-comment"><p>2) The rationale for donor selection is unclear and potentially problematic. The non-T300A donors may be key to interpretation of the experiments and establishing baseline. Similarly, the T300A genotype does not appear to have a contribution towards microbiome composition in UC, although we cannot say that for sure with the current analysis. It is unclear mechanistically why it matters whether the sample is from UC vs CD with the same genotype. Also, why is the healthy control heterozygous for T300A? A related issue is the low N number for human donors. These differences between conditions (health status and genotype) may be a reflection of random donor heterogeneity.</p></disp-quote><p>To address these concerns, we analyzed sequencing data from T300A mice associated with stool from a patient with inactiveCrohn’s disease and without a mutation in the <italic>ATG16L1</italic> gene which we include in the re-submission. These data are found in Figure 3.</p><p>Indeed, the composition of the microbiota can vary from person to person and within an individual with IBD during a flare and in remission.</p><p>The availability of donor human stool that was collected at clinic and immediately flash frozen was limited. The ideal combinations of appropriately collected sample and individual phenotype and genotype were not available to us.</p><p>We have incorporated text into the manuscript that more thoroughly addresses donor selection, sample collection challenges, and sample heterogeneity.</p><p>As to why the healthy control is heterozygous for T300A, the guanine to alanine substitution, which converts a threonine to alanine at position 300 in ATG16L1, is a relatively common mutation in healthy individuals. Hampe et al. have shown that the frequency of the G allele is 0.53 in control individuals. We have explained this more clearly and in more detail in the text of the re-submitted manuscript.</p><disp-quote content-type="editor-comment"><p>3) A more thorough examination of the immune compartment is needed. There is a sense that the authors are finding what they're looking for.</p></disp-quote><p>We agree that more subsets of T cells as well as myeloid cells can be altered under these conditions and in the context of IBD. We have additional data on Foxp3+ regulatory T cells, Gata3<sup>+</sup> Th2 cells as well as a variety of myeloid cell subsets including CD11c<sup>+</sup>MHCII<sup>+</sup> dendritic cells, CD103<sup>+</sup> “tolerogenic” dendritic cells, CD11b<sup>+</sup>GR-1<sup>+</sup> neutrophils and inflammatory monocytes from our gnotobiotic association studies that are now included in Figures 6, 7 and 8 in the re-submitted manuscript.</p><disp-quote content-type="editor-comment"><p>4) Details regarding co-housing, gender, and littermates are missing. Depending on how the experiments were performed, a subset may need to be repeated under appropriate conditions to validate the initial findings.</p></disp-quote><p>We provide information on caging, gender, and littermates as requested by the reviewers in Supplementary file 1.</p><p>We carried out the following experiments to ameliorate these concerns and significantly enhance the mechanism we present in the manuscript.</p><p>We now include experiments that involve associating germ-free (GF) mice and mice with a limited microbiota (Altered Schaedler Flora – ASF mice) with an individual strain of <italic>Bacteroides ovatus</italic> (ATCC 8483). We completed experiments that involved associating WT and T300A cage-matched, age-matched GF and ASF mice with or without <italic>Bacteroides ovatus</italic>. These data are found in Figure 7 and Figure 8</p><p>Data from these experiments address the question of whether T300A mice housed with WT mice show differences in gut immune populations by flow cytometry in the presence of <italic>B. ovatus</italic>. We also analyzed the gut tissue for signs of damage, hyper-proliferation, inflammation and any abnormalities observed on histology-based review of these tissues.</p><p>Mechanistically, these experiments reveal the effect of <italic>B. ovatus</italic> alone on the gut immune response. We are focusing on <italic>B. ovatus</italic>, as this species was enriched in T300A mice associated with active Crohn’s disease stool, but not in mice associated with stool from patients with active ulcerative colitis in Figure 4 of our manuscript. These findings correlated with increases in Th17 cells in the gut of T300A mice associated with active Crohn’s disease stool. As mentioned in the manuscript text, previous studies have shown a potential effect of <italic>Bacteroides spp</italic>. on Th17 populations in the gut. These new studies that are now part of the resubmitted manuscript specifically address whether an isolate from this species alone or in concert with the ASF can alter Th17 frequency in the gut of T300A mice.</p><p>Summary of experiments and textual revisions in this re-submission:</p><p>Experimental Revisions:</p><p>a) Inclusion of data on donor input microbiome sample, see Figure 3A.</p><p>b) Inclusion of data from DSS experiment, e.g. weight trajectories from T300A and WT mice, see Figure 2E.</p><p>c) Inclusion of pre-DSS microbiome analyses and colitis scores of T300A and WT conventional mice, see Figure 1.</p><p>d) Inclusion of data on flow cytometry profiles from gnotobiotic experiments on Th2, Treg, and myeloid cells subsets, see Figure 6.</p><p><italic>e) B. ovatus</italic> gnotobiotic experiments with lamina propria immune subset profiling, see Figure 7 and Figure 8.</p><p>Textual Revisions:</p><p>a) Improved textual explanation of donor selection for gnotobiotic experiments.</p><p>b) Inclusion of metadata from gnotobiotic experiments, e.g. mouse gender and caging.</p><p>c) Fixed typos mentioned by reviewer number 2.</p><disp-quote content-type="editor-comment"><p>Reviewer #1:</p><p>[…] 1) GWAS studies have linked over 230 genetic risk loci to increased IBD risk but this manuscript addresses only one and even when transferring stool from active Crohn disease patient does not cause experimental colitis per se. Further, already published work has shown that NOD2 variants, which may interact in aberrant manner withATG16L1, predispose to dysbiosis – see Knights et al., 2014.</p></disp-quote><p>Due to the complex nature of IBD and the abundance of SNPs associated with disease, we assert that it is important to look at individual SNPs separately to carry out mechanistic studies aimed out unraveling disease causality.</p><disp-quote content-type="editor-comment"><p>2) Alterations in mouse fecal microbiota are only noted in in SPF T300A vs. WT mice following on the generation of gut inflammation, as in Figure 1. It appears that the T300A risk allele may specifically enhance Bacteroides spp.</p><p>3) Data on the basal microbiome are not provided in quiescent &quot;control&quot; state given that T300A mice do not spontaneously develop intestinal inflammation.</p></disp-quote><p>We have responded to reviewer #1’s comments 2 and 3 in the main response number 1 above.</p><disp-quote content-type="editor-comment"><p>4) In Figure 2, concise data indicate stability of microbiome diversity and changes in control and mutant mice, as dictated by human donor stool status. It is unclear why the healthy volunteer is in fact genotype heterozygous T300A (AG), when even the intermediate phenotype appears to impact the microbiome? Could this be addressed?</p><p>5) In Figure 3, the authors show increase in Bacteroides in T300A mice that received stool from active Crohn disease, and there are little changes noted in mice receiving stool from active UC patient. Test samples are from small numbers (n=1) of patients, as alluded to by authors.</p><p>6) Interestingly, T300A selectively appears to impact gut T cell populations in mice receiving Crohn disease stool (Figure 4) albeit there is no disease induction. In all mice, stool from all sources appears to increase T cells, relative to germ free mice but there are no RORγt T cells increments. There is no substantive colitis induced by donor stool transfer in the experiments reported –Figure 6—figure supplement 3.</p><p>7) Patient genotype data and stool microbiome data available from Jostins et al. in ref. 7, suggest that T300A in humans conveys a trend to increase Bacteroides fragilis, but not robustly with respect to the genus Bacteroides and not in a generally significant manner. (Figure 5). The authors suggest that T300A seems to reconfigure the human microbiota and importantly even the presence of a heterozygous genotype displays an intermediate phenotype with respect to Bacteroides species.</p></disp-quote><p>These comments have been addressed in main response number 2 above and in the text of the manuscript as well.</p><disp-quote content-type="editor-comment"><p>Reviewer #2:</p><p>[…] 1) After 7 days of DSS, followed by 7 days of water is there a difference in weight loss or rebound kinetics between WT and T300A mice? Microbiome analysis pre-DSS colitis would be helpful to support the data in Figure 1, and can be provided as supplemental material.</p><p>The differences in microbial communities during inflammation between WT vs T300A mice are intriguing. However, during steady-state (no DSS) conditions, how do the microbiome compare? Are the differences observed during DSS colitis also present during naïve conditions? Is the bloom in Bacteroides due to DSS and inflammation? The authors state that these &quot;changes occur before the onset of disease, suggesting that ATG16L1 T300A may contribute initially to dysbiosis […]&quot; – if this is the case, do you observe increased Bacteroides before DSS colitis induction?</p><p>This is important since the following figure (Figure 2) show distinct communities between WT vs T300A recipient mice upon transplantation with CD active microbiota, conceivably in an inflammatory setting analogous to DSS conditions of Figure 1.</p></disp-quote><p>We have addressed reviewer # 2 concerns in comment 1 in the main response number 1 above.</p><p>We include the weight trajectory data for DSS treated mice in the resubmission.</p><disp-quote content-type="editor-comment"><p>2) Along the same lines, do you observe an enrichment of Bacteroides spp. in CD active donor samples (in T300A or WT recipients) vs. CD inactive donor samples? The UC controls are informative, but how does CD active compare to CD inactive in respects to Bacteroides abundance?</p><p>3) The donors from healthy control and CD patients were nicely controlled, with all donors with T300A genotype. Were any experiments performed with T300 donors (healthy/CD active/CD inactive)? If so, how do they compare in the analysis in PCA plots (Figure 2A)? It appears that host genotype (T300A) of donor alone is not sufficient drive changes in the composition of the microbiota, as both WT and T300A mice cluster closely together when colonized with active UC T300A donors but not active CD T300A donors (Figure 2B).</p><p>Additionally, the authors note that &quot;the differences in the active CD microbiota in mice are due to the presence of the risk allele T300A as opposed to microbial population drift due to human stool transfer into mice alone&quot; – if this is the case, would the authors predict that T300 donors with active CD result in no differences when transplanted into WT and T300A recipient mice? This control would also be relevant when examining Bacteroides abundance to support the claim that &quot;T300A has the potential to drive increases in Bacteroides spp.&quot;. Perhaps the authors can refer to the data in Figure 5, and look at animals colonized with WT or Het to compare with T300A samples.</p></disp-quote><p>We have noted that we included information regarding association of T300A mice with stool from a patient with inactive CD and a WT genotype.</p><disp-quote content-type="editor-comment"><p>4) In Figure 2B, how does the microbiome of WT and T300A recipients (CD or UC) compare to the initial donor sample? Is there more drift in one genotype vs. the other?</p></disp-quote><p>We have 16S rRNA gene amplicon data on human stool samples pre-association that are included in the re-submitted manuscript.</p><disp-quote content-type="editor-comment"><p>Reviewer #3:</p><p>[…] Figure 1:</p><p>– Analysis of microbial diversity in animal studies is complex and requires thorough description of the approach used. While the figure and legend provide some level of detail, it would be useful to more clearly state if animals were gender matched, if there was a gender bias observed.</p></disp-quote><p>We provide information on gender in our analysis. We find this topic compelling and in these experiments we did not find differences related to gender in the mice.</p><disp-quote content-type="editor-comment"><p>– Given the strong association of the T300A variant with ileal Crohn's disease, why was ileal &quot;fecal&quot; content not assessed in this study? An attempt to perform this analysis, or a clear rationale as to why it wasn't attempted would benefit the reader.</p></disp-quote><p>We think that because human stool samples are collected as passed fecal samples and not ileal samples, we wanted to remain consistent with how these human samples were collected when we conducted our mouse microbiota studies.</p><disp-quote content-type="editor-comment"><p>Figure 2:</p><p>– Details regarding co-housing and gender(s) used, along with any gender bias if observed, would benefit the reader again. Were all recipients co-housed (either in pairs or other protocols) throughout the study?</p></disp-quote><p>This comment has been addressed in the main response number 4 above.</p><disp-quote content-type="editor-comment"><p>Figure 4:</p><p>– What are the baseline alterations in gut immune cell populations in conventionally co-housed WT vs. T300A mice (from Figure 1)?</p><p>– Is the impact on Th1/Th17 abundance cell autonomous? Would adoptive transfer of T300A T cells into a WT recipient reproduce this phenotype? If not, it is an interesting observation as well since it would implicate additional host factors in driving T cell polarization.</p></disp-quote><p>We think that these experiments, while important, cannot be completed in a two month time frame.</p><disp-quote content-type="editor-comment"><p>– Authors only assessed specific T cell subsets, while the T300A genotype is germline. How does the T300A genotype impact abundance and/or function of other immune cell subsets relevant to IBD? Presenting data on Treg, NK/NKT, gdTcells or other tissue resident T cells, macrophage/monocyte, dendritic cell and B cell populations would be highly relevant.</p></disp-quote><p>We have addressed this with additional data mentioned in the main response number 3 above.</p><disp-quote content-type="editor-comment"><p>– Given the expansion of RORc<sup>+</sup> CD4<sup>+</sup> T cells in the ileum lamina propria, are IL-23 producing DCs or myeloid cells overabundant? A simple measurement of IL12/23 family cytokines from intestinal explants in this study may provide the answer.</p><p>Figure 5:</p><p>– A discussion on how the observed dysbiosis may reflect on ileal flora would be useful here, given that the T300A variant is strongly associated with ileal CD.</p></disp-quote><p>We did not collect data on IL-23 or collect ileal contents. However, we provide data on Il-23 transcript levels from the lamina propria of the colon and ileum in Figure 9 wherein we show data demonstrating increased expression of <italic>Il23p19</italic> in lamina propria from the colon and ileum of T300A ASF mice associated with <italic>Bacteroides ovatus</italic> 8483.</p></body></sub-article></article>